Discover B2B leads for Pharmaceuticals industry
Identify and research relevant prospects for B2B lead generation on Pharmaceuticals sector. Find their verified contact details to reach out to them, nurture and convert them into paying clients. Streamline the process of filtering B2B prospects by searching for bisinesses based on their specifics like location, name or category.
Businesses
Found 257 in our database
Found 1977 in our records
HQ: North Chicago, Illinois, United States
AbbVie
AbbVie is a pharmaceutical company that discovers,Show more... develops, and markets medicines.
HQ: North Chicago, Illinois, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 22, 2024
Founded Date: 2013
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NYSE:ABBV
Operating Status: Active
325 Emails
0 Phones
Main email format: sarah.smith@abbvie.com (59.3%)
-
Richard A Gonzalez
r**************z@abbvie.com
-
Jonathan Pound
Sr Specialty Representative
j************d@abbvie.com
-
Andrew Dillard
a************d@abbvie.com
-
Jennifer Langan
j*************n@abbvie.com
-
Jay Stamatis
j**********s@abbvie.com
-
Miki Mancine
m**********e@abbvie.com
-
Catherine Desjardins
Regional Manager, Market Access and Government Affairs in Oncology
c******************s@abbvie.com
-
Felix J Gonzalezreyes
f*****************s@abbvie.com
-
Ateet Shah
a********h@abbvie.com
-
Robert Michael
President and Chief Operating Officer
r****t@abbvie.com
-
Tim Hale
t******e@abbvie.com
-
Kumar Kantheti
Head of Customer Insights at Regeneron Pharmaceuticals, Inc.
k************i@abbvie.com
-
Alfonso Savoia
a************a@abbvie.com
-
Marie-Charlotte GOFF
m*******************f@abbvie.com
-
Carrie Strom
Senior Vice President, US Medical Aesthetics
c**********m@abbvie.com
-
Glen Curran
Vice President, Marketing, US Eyecare
g*********n@abbvie.com
-
Jessica Campagna
Director, Regulatory Affairs
j**************a@abbvie.com
-
Natalie Anderten
Director, Clinical Development Operations
n**************n@abbvie.com
-
Gamal Ferrer
Supply Planning Manager
g**********r@abbvie.com
-
Alex Selsky
a*********y@abbvie.com
-
Bill Pappano
b**********o@abbvie.com
-
Laurence Pierard
l**************d@abbvie.com
-
Jane Woo
j******o@abbvie.com
-
Liz Lloyd
l*******d@abbvie.com
-
Francescaeugenia Civardi
f**********************i@abbvie.com
-
Eric Nelson
e*********n@abbvie.com
-
Hanne Vanspaendonk
h****************k@abbvie.com
-
Jacob Degner
j**********r@abbvie.com
-
Nestor Ortiz
n**********z@abbvie.com
-
Philip Mcquain
p************n@abbvie.com
-
Tamar Uziel
t*********l@abbvie.com
-
Jill Hoeger
j*********r@abbvie.com
-
Ahmed Othman
a**********n@abbvie.com
-
Earle Bain
e********n@abbvie.com
-
Lisa Greenstein
l*************n@abbvie.com
-
Samrat Mukherjee
s**************e@abbvie.com
-
Lloyd Lam
l*******m@abbvie.com
-
Joshua Plotnik
j************k@abbvie.com
-
Stephen Fortino
s*************o@abbvie.com
-
Robert A Love
r***********e@abbvie.com
-
Tino Seidel
t*********l@abbvie.com
-
John Engelhardt
j*************t@abbvie.com
-
Mk Steel
m******l@abbvie.com
-
Carlos Taveras
c************s@abbvie.com
-
Jens Herrfurth
j************h@abbvie.com
-
Carola Vogt
c*********t@abbvie.com
-
Ariel Ting
a********g@abbvie.com
-
Anja Moeller
a**********r@abbvie.com
-
Scott Filarski
s************i@abbvie.com
-
Joachim Vogt
j**********t@abbvie.com
-
Josue Samayoa
j***********a@abbvie.com
-
Krystal Loewe
k***********e@abbvie.com
-
Jan Lohne
j*******e@abbvie.com
-
Bei Chen
b******n@abbvie.com
-
Francesca Marrani
f***************i@abbvie.com
-
Silvija Vaitkiene
s***************e@abbvie.com
-
Thorsten Pflanzner
t****************r@abbvie.com
-
Sara Orndoff
s**********f@abbvie.com
-
Antonis Papasolomontos
a********************s@abbvie.com
-
Philipp Huwe
p**********e@abbvie.com
-
Krystal Bruno
k***********o@abbvie.com
-
Lisa Miller
l*********r@abbvie.com
-
Erica Gruvberg
e************g@abbvie.com
-
Lavina Harjani
l************i@abbvie.com
-
Andrew D Vogt
a***********t@abbvie.com
-
Meri Oliva
m********a@abbvie.com
-
Mariadelcarmen Estrada
m********************a@abbvie.com
-
Elena Dianova
e***********a@abbvie.com
-
Dawn George
d*********e@abbvie.com
-
Kent Pearson
k**********n@abbvie.com
-
Kei Takatsu
k*********u@abbvie.com
-
Johannes Huelsenbeck
j******************k@abbvie.com
-
Shunya Urata
s**********a@abbvie.com
-
Sebastian Koob
s************b@abbvie.com
-
Paul E Kroeger
p************r@abbvie.com
-
Be Mnp
b****p@abbvie.com
-
Christopher Kwok
c**************k@abbvie.com
-
Brendan Mccarthysinclair
b**********************r@abbvie.com
-
Margaret Fettiskoenders
m*********************s@abbvie.com
-
Pv Saudiarabia
p************a@abbvie.com
-
Carleigh Kmetz
c************z@abbvie.com
-
Ed Reilly
e*******y@abbvie.com
-
Cyril Ramathal
c************l@abbvie.com
-
Xin X Lu
x******u@abbvie.com
-
Adrian Hobson
a***********n@abbvie.com
-
Jason Holbert
j***********t@abbvie.com
-
Susan Bale
s********e@abbvie.com
-
Cynthia Waseity
c*************y@abbvie.com
-
Michal Roszkowski
m***************i@abbvie.com
-
Mike Dennis
m*********s@abbvie.com
-
Robert Grundman
r*************n@abbvie.com
-
Sebastian Wachtarz
s****************z@abbvie.com
-
Michael R Robinson
m****************n@abbvie.com
-
Mansour Dughbaj
m*************j@abbvie.com
-
Yixin Fang
y********g@abbvie.com
-
Lisa Hazelwood
l************d@abbvie.com
-
Hannah Palac
h**********c@abbvie.com
-
Yu Deng
y*****g@abbvie.com
-
Elizabeth Shea
e************a@abbvie.com
-
Sarah Beck
s********k@abbvie.com
-
Natalie Bennett
n*************t@abbvie.com
-
Cheryl Pitcher
c************r@abbvie.com
-
Joanna Jones
j**********s@abbvie.com
-
Nancy Sever
n*********r@abbvie.com
-
Kim Hogan
k*******n@abbvie.com
-
David Maag
d********g@abbvie.com
-
Hetal Sarvaiya
h************a@abbvie.com
-
Yuki Koshi
y********i@abbvie.com
-
Stevan W Djuric
s*************c@abbvie.com
-
Hiroki Matsuo
h***********o@abbvie.com
-
Martha Titler
m***********r@abbvie.com
-
Alexandra Smith
a*************h@abbvie.com
-
Lauren Himmel
l***********l@abbvie.com
-
Forrest Weghorst
f**************t@abbvie.com
-
Nakesha Spellman
n**************n@abbvie.com
-
Parul Singh
p*********h@abbvie.com
-
Isheeta Shah
i**********h@abbvie.com
-
Christian Sanandres
c*****************s@abbvie.com
-
Anil Vasudevan
a************n@abbvie.com
-
Justin Rayyan
j***********n@abbvie.com
-
James Marek
j*********k@abbvie.com
-
Sophee Blanthornhazell
s********************l@abbvie.com
-
Rahul Mehta
r*********a@abbvie.com
-
Javier Leaniz
j***********z@abbvie.com
-
Jit Bhowmick
j**********k@abbvie.com
-
David Masica
d**********a@abbvie.com
-
Robert Mclaughlin
r***************n@abbvie.com
-
Anuj Verma
a********a@abbvie.com
-
Jianzhen Chan
j***********n@abbvie.com
-
Stephanie Weinstein
s*****************n@abbvie.com
-
Brian C Anderson
b**************n@abbvie.com
-
Karol Charkiewicz
k***************z@abbvie.com
-
Shawn Jeffries
s************s@abbvie.com
-
Stacy Sullivan
s************n@abbvie.com
-
Geoff Gz Zhang
g************g@abbvie.com
-
Namita Tundia
n***********a@abbvie.com
-
Sarah Doupe
s*********e@abbvie.com
-
Chris Medina
c**********a@abbvie.com
-
Takafumi Tanaka
t*************a@abbvie.com
-
Razaq Salau
r*********u@abbvie.com
-
Chelsea Parrocha
c**************a@abbvie.com
-
Jane Qian
j*******n@abbvie.com
-
Bryan Rogers
b**********s@abbvie.com
-
Michael Kaltschmidt
m*****************t@abbvie.com
-
Jeroen Schrevens
j**************s@abbvie.com
-
Jamie Chouinard
j*************d@abbvie.com
-
Jeffrey Waite
j***********e@abbvie.com
-
Jason Hart
j********t@abbvie.com
-
Jules Holland
j***********d@abbvie.com
-
Melvin Munsaka
m************a@abbvie.com
-
Namjin Chung
n**********g@abbvie.com
-
Ning Sun
n******n@abbvie.com
-
Edward Ronan
e**********n@abbvie.com
-
Niharika Chauhan
n**************n@abbvie.com
-
Lin Zhu
l*****u@abbvie.com
-
Anna Levi
a*******i@abbvie.com
-
Giuliana Gualberti
g****************i@abbvie.com
-
Naoki Wasa
n********a@abbvie.com
-
Zoltan Dezso
z**********o@abbvie.com
-
Reyhaneh Nazarian
r***************n@abbvie.com
-
Nam Bui
n*****i@abbvie.com
-
Dalila Miele
d**********e@abbvie.com
-
Keturah Kiper
k***********r@abbvie.com
-
Andrella King
a***********g@abbvie.com
-
Sana Khajehpour
s*************r@abbvie.com
-
Rebecca Kattan
r************n@abbvie.com
-
Jerry Jacob
j*********b@abbvie.com
-
Heather Huang
h***********g@abbvie.com
-
Catherine Ho
c**********o@abbvie.com
-
Melanie Flores
m************s@abbvie.com
-
Payal Bhatt
p*********t@abbvie.com
-
Laura Gasparini
l*************i@abbvie.com
-
Kartik Anne
k*********e@abbvie.com
-
Minna Abdelaziz
m*************z@abbvie.com
-
Josette Hughes
j************s@abbvie.com
-
Megan Jimerson
m************n@abbvie.com
-
Teresa K Oberlander
t*****************r@abbvie.com
-
Roland Heym
r*********m@abbvie.com
-
Aoi Kurano
a********o@abbvie.com
-
Jeff Onyskiw
j**********w@abbvie.com
-
Jodi Walker
j*********r@abbvie.com
-
Evgenyi Shalaev
e*************v@abbvie.com
-
Yunzhao Xing
y**********g@abbvie.com
-
Aparna Shinde
a***********e@abbvie.com
-
Leonie Hammer
l***********r@abbvie.com
-
Gregory Willocq
g*************q@abbvie.com
-
Bobbi Wiggins
b***********s@abbvie.com
-
Yoosook Kim
y*********m@abbvie.com
-
John Torrisi
j**********i@abbvie.com
-
Barbara Razenberg
b***************g@abbvie.com
-
Matthew Galley
m************y@abbvie.com
-
Emily King
e********g@abbvie.com
-
Gentry Lassiter
g*************r@abbvie.com
-
Elena Karpilovski
e***************i@abbvie.com
-
Liz Shea
l******a@abbvie.com
-
Ilke Limoncu
i**********u@abbvie.com
-
Alyssa Rege
a*********e@abbvie.com
-
Raquel Powers
r***********s@abbvie.com
-
Jeremy Picard
j***********d@abbvie.com
-
Adelle Infante
a************e@abbvie.com
-
Todd Bosse
t********e@abbvie.com
-
Joao N Belo
j*********o@abbvie.com
-
Jaquelin Finley
j*************y@abbvie.com
-
Gerlinde Baldauf
g**************f@abbvie.com
-
V Siparis
v*******s@abbvie.com
-
Jenna Hanson
j**********n@abbvie.com
-
David Wagner
d**********r@abbvie.com
-
Isabelle Petatthiolas
i*******************s@abbvie.com
-
Anisha Manix
a**********x@abbvie.com
-
Jacqueline Karis
j**************s@abbvie.com
-
Suzanne Barston
s*************n@abbvie.com
-
Shannelle Fowler
s**************r@abbvie.com
-
Dana Harville
d***********e@abbvie.com
-
Gabrielle Tarbert
g***************t@abbvie.com
-
Susanne Griffiths
s***************s@abbvie.com
-
Larry Peepo
l*********o@abbvie.com
-
Gregory Miley
g***********y@abbvie.com
-
Courtney Fella
c************a@abbvie.com
-
Jonathan Anderson
j***************n@abbvie.com
-
Jenina Nunez
j**********z@abbvie.com
-
Moiz Diwan
m********n@abbvie.com
-
Tym Lindsey
t*********y@abbvie.com
-
Office At
o*******t@abbvie.com
-
Mandie Judy
m*********y@abbvie.com
-
Fabio Lievano
f***********o@abbvie.com
-
Thao T Doan
t*********n@abbvie.com
-
Peter Bacher
p**********r@abbvie.com
-
Birgitta Bjornek
b**************k@abbvie.com
-
Joy Jacksonguilford
j******************d@abbvie.com
-
Rebecca Kohnken
r*************n@abbvie.com
-
Elizabeth Simms
e*************s@abbvie.com
-
Lucas Chavira
l***********a@abbvie.com
-
David Gardner
d***********r@abbvie.com
-
Juliapaige Yuhase
j***************e@abbvie.com
-
Fernando Bastos
f*************s@abbvie.com
-
Yunhao Tan
y********n@abbvie.com
-
Hongjian Zhu
h**********u@abbvie.com
-
Carlos Hader
c**********r@abbvie.com
-
Samira Mawla
s**********a@abbvie.com
-
Fabian Liboschik
f**************k@abbvie.com
-
Petra Grossmann
p*************n@abbvie.com
-
Anna Samokhvalova
a***************a@abbvie.com
-
Dai Feng
d******g@abbvie.com
-
Iain Boomer
i*********r@abbvie.com
-
Alice Chan
a********n@abbvie.com
-
Megana Vatson
m***********n@abbvie.com
-
Amanda Vogel
a**********l@abbvie.com
-
Jun Yu
j****u@abbvie.com
-
Kevin Zowaski
k***********i@abbvie.com
-
Eva Sebestova
e***********a@abbvie.com
-
Kathrin Kuntz
k***********z@abbvie.com
-
Brian Martin
b**********n@abbvie.com
-
Jijie Gu
j******u@abbvie.com
-
Andrew Shaw
a*********w@abbvie.com
-
Florian Dieckmann
f***************n@abbvie.com
-
David Freundel
d************l@abbvie.com
-
Javier Boix
j*********x@abbvie.com
-
Tamer Hanna
t*********a@abbvie.com
-
Diana L Donnellyroberts
d**********************s@abbvie.com
-
Dayoung Yi
d********i@abbvie.com
-
Renee Heuser
r**********r@abbvie.com
-
Blai Coll
b*******l@abbvie.com
-
Muriel Haraoui
m************i@abbvie.com
-
Daniela Haertel
d*************l@abbvie.com
-
Sanjay Bhardwaj
s*************j@abbvie.com
-
Kaisa Raitio
k**********o@abbvie.com
-
Sabine Grote
s**********e@abbvie.com
-
Johanna Castrillon
j****************n@abbvie.com
-
Veronique Paula
v*************a@abbvie.com
-
Christina Lee
c***********e@abbvie.com
-
Gary Chiang
g*********g@abbvie.com
-
Marketta Piskonen
m***************n@abbvie.com
-
Aman Thukral
a**********l@abbvie.com
-
Julie Lepsetz
j***********z@abbvie.com
-
Hannah Martinez
h*************z@abbvie.com
-
Aris Vasilopoulos
a***************s@abbvie.com
-
Ryota Watanabe
r************e@abbvie.com
-
Takao Nito
t********o@abbvie.com
-
Weili He
w******e@abbvie.com
-
Mabel Martinez
m************z@abbvie.com
-
Devin Slagle
d**********e@abbvie.com
-
Eileen Murphy
e***********y@abbvie.com
-
Giuseppina Zarigno
g****************o@abbvie.com
-
Eric Mohler
e*********r@abbvie.com
-
Min Zhang
m*******g@abbvie.com
-
Terhi Pellinen
t************n@abbvie.com
-
Anne Lejon
a********n@abbvie.com
-
Marcello Rinaldi
m**************i@abbvie.com
-
Ryoichi Kiyohara
r**************a@abbvie.com
-
Jillian Griffin
j*************n@abbvie.com
-
Shuai Hao
s*******o@abbvie.com
-
Jessica Feltman
j*************n@abbvie.com
-
Jeffrey Allan
j***********n@abbvie.com
-
Frank Benenati
f************i@abbvie.com
-
Shashank Shekhar
s**************r@abbvie.com
-
Roxann Stubbs
r***********s@abbvie.com
-
Medha Tomlinson
m*************n@abbvie.com
-
Beatriz Samanes
b*************s@abbvie.com
-
Kate Ferrario
k***********o@abbvie.com
-
Nicole Muraca
n***********a@abbvie.com
-
Jay Lucas
j*******s@abbvie.com
-
Helene Villeneuve
h***************e@abbvie.com
-
Pascal Marcoux
p************x@abbvie.com
-
Nathalie Lavoie
n*************e@abbvie.com
-
Theresia Bredenwall
t*****************l@abbvie.com
-
Customer Service
customerservice@abbvie.com
-
Unclassified inbox
talentacquisition@abbvie.com
-
Unclassified inbox
AbbvieCDO@abbvie.com
-
Unclassified inbox
privacydsr@abbvie.com
-
Unclassified inbox
info-cz@abbvie.com
-
Unclassified inbox
abbviemediarelations@abbvie.com
-
Unclassified inbox
switzerland@abbvie.com
-
Unclassified inbox
orders@abbvie.com
-
Unclassified inbox
abbviemediarelations@abbvie.com
-
Unclassified inbox
medical_info_spain@abbvie.com
-
Unclassified inbox
safety-cz@abbvie.com
-
Unclassified inbox
plsproductsurveillanceteam@abbvie.com
-
Customer Service
customerservice@abbvie.com
-
Unclassified inbox
hrconnect.northamerica@abbvie.com
-
Unclassified inbox
abbviepaa@abbvie.com
-
Unclassified inbox
managepd_support_it@abbvie.com
-
Unclassified inbox
library@abbvie.com
-
Unclassified inbox
job-opportunities@abbvie.com
-
Unclassified inbox
sp-assuntos_regulatorios@abbvie.com
-
Unclassified inbox
cs-germany@abbvie.com
-
Customer Service
service@abbvie.com
-
Unclassified inbox
info.de@abbvie.com
HQ: Rahway, New Jersey, United States
Merck
Merck is a biopharmaceutical company that offers mShow more...edicines and vaccines for various diseases.
HQ: Rahway, New Jersey, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 28, 2024
Founded Date: 1891
Number of Exits: 9
Company Type: For Profit
Stock Symbol: NYSE:MRK
Operating Status: Active
44 Emails
0 Phones
Main email format: sarah_smith@merck.com (76.9%)
-
Phillip Samayoa
Associate Director, MRL Ventures
p******s@merck.com
-
Joseph Schaller
j*************r@merck.com
-
Joseph Schaller
j*************r@merck.com
-
Eliav Barr
Vice President, Infectious Diseases
e********r@merck.com
-
Peter Honigmann
p*************n@merck.com
-
Rob Davis
r*******s@merck.com
-
Dean Li
Senior Vice President of Discovery Sciences and Translational Medicine
d*****i@merck.com
-
Dean Li
Senior Vice President of Discovery Sciences and Translational Medicine
d****i@merck.com
-
Renee Suhr
r********r@merck.com
-
Caroline Litchfield
c*****************d@merck.com
-
Todd Herman
t*********n@merck.com
-
Todd Herman
t*********n@merck.com
-
Eunkyung Kauh
e***********h@merck.com
-
Cameron Downie
c************e@merck.com
-
Cameron Downie
c************e@merck.com
-
Martin Khun
m*********n@merck.com
-
Martin Khun
m*********n@merck.com
-
Joe Volpe
j**********e@merck.com
-
Lubomir Kamensky
l**************y@merck.com
-
Carolina Colella
c**************a@merck.com
-
Rachel Parise
PhD Candidate - Analytical Chemistry Reseacher
r***********e@merck.com
-
Peter Dudek
Associate
p*********k@merck.com
-
Marc Gailhardou
a VP Global Oncology Strategy at Merck
m*************u@merck.com
-
Jieyun Hao
HR Business Partner
j********o@merck.com
-
Francesca Poggio
f**************o@merck.com
-
Ken Friesen
k*********n@merck.com
-
Austin Snook
a**********k@merck.com
-
Roberta Corsi
r***********i@merck.com
-
Vishal Sahni
Venture Capital advisory committee member, Biofund II
v**********i@merck.com
-
John Minehane
Assistant Production Manager
j***********e@merck.com
-
Cheryl Donnelly
c*************y@merck.com
-
Courtney Ronaldo
c**************o@merck.com
-
Tracy Clemmer
t************2@merck.com
-
Harry Herar
Sales Representative
h*********r@merck.com
-
Andrei Manica
a***********a@merck.com
-
Sergey Zverev
s***********v@merck.com
-
Rehan A Khan
r********n@merck.com
-
Kevin Ali
k*******i@merck.com
-
Kevin Sharpe
k**********e@merck.com
-
Heather Rakestraw
h***************w@merck.com
-
Cedric Grand-Pierre
c****************e@merck.com
-
Joyce. Pennings
j************s@merck.com
-
Anneke Rietveld
Key Account Manager
a*************d@merck.com
-
Legal Department
legal@merck.com
HQ: New York, New York, United States
Pfizer
Pfizer is a biopharmaceutical company that provideShow more...s affordable access to safe, effective medicines and health care services.
HQ: New York, New York, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 9, 2024
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital
42 Emails
0 Phones
Main email format: sarah.smith@pfizer.com (92.1%)
-
Rebecca Hamm
Senior Director, Communications
r**********m@pfizer.com
-
Christopher Conner
US Field Medical Excellence Vaccines + Antivirals
c****************r@pfizer.com
-
Adam Guhle
Oncology Category Lead
a********e@pfizer.com
-
Neil Campbell
Senior Director, Pfizer Global Supply
n***********l@pfizer.com
-
Mathieu Poirier
Therapeutic Area Lead, Global Commercial Access Partnerships
m*************r@pfizer.com
-
Jennifer Lafontaine
VP, Head of Oncology Medicinal Chemistry
j*****************e@pfizer.com
-
Mike Mcdermott
Chief Global Supply Officer, Executive Vice President
m************t@pfizer.com
-
Sally Susman
Executive Vice President and Chief Corporate Affairs Officer
s**********n@pfizer.com
-
Kathrin Jansen
Senior Vice President and Head of Vaccine R&D
k************n@pfizer.com
-
Paul Fitzgerald
Energy, Utilities and Facilities Services Lead
p*************d@pfizer.com
-
Julie Jenson
Director Corporate Responsibility
j***********n@pfizer.com
-
Suzanna Ladas
Source to Contract Operations
s***********s@pfizer.com
-
David Breen
Site Leader, Algete, Madrid, Spain
d*********n@pfizer.com
-
Alfredo Linares
Vice President, People Experience, Organizational Development and Communications, PGS Division
a*************s@pfizer.com
-
Nooshin Rahimi
Professional Healthcare Representative
n************i@pfizer.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k***********i@pfizer.com
-
Prabhu Kundurthy
p**************y@pfizer.com
-
Steven Ph.D.
s********x@pfizer.com
-
Nina Jochnowitz
Business Analyst
n*************z@pfizer.com
-
Loucineh Mardirossian
Director, Communications
l*******************n@pfizer.com
-
Keith Jago
k********o@pfizer.com
-
Shaan Gandhi
Board Member
s**********i@pfizer.com
-
Cindy Schmidt
c***********t@pfizer.com
-
letizia greggi
l************i@pfizer.com
-
Azzurra Ravizza
a*************a@pfizer.com
-
Jane Kuczma
Director, Clinical Data Management
j*********a@pfizer.com
-
Agnes Hong
a********g@pfizer.com
-
Heather Cisek
h***********k@pfizer.com
-
Matthew Badland
m*************d@pfizer.com
-
Yulia Ivanova
y***********a@pfizer.com
-
Dario Bottaro
d***********o@pfizer.com
-
Brigitte TEXIER
b*************r@pfizer.com
-
Ron Cherepuschak
r**************k@pfizer.com
-
Johanna
j*****a@pfizer.com
-
Rasid Kamal
r*********l@pfizer.com
-
Liesbet Symoens
l*************s@pfizer.com
-
Erica Cline Reading
e***********g@pfizer.com
-
Jaclyn McNelis, MSHRM
j************s@pfizer.com
-
Christine Mckenna
Consultant
c***************a@pfizer.com
-
Juan Borger
j*********r@pfizer.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k****n@pfizer.com
-
Prabhu Kundurthy
prabhu@pfizer.com
-
General Inquiries
info@pfizer.com
HQ: New York, New York, United States
Pfizer
Pfizer is a biopharmaceutical company that provideShow more...s affordable access to safe, effective medicines and health care services.
HQ: New York, New York, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 3, 2024
Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital
42 Emails
0 Phones
Main email format: sarah.smith@pfizer.com (92.1%)
-
Rebecca Hamm
Senior Director, Communications
r**********m@pfizer.com
-
Christopher Conner
US Field Medical Excellence Vaccines + Antivirals
c****************r@pfizer.com
-
Adam Guhle
Oncology Category Lead
a********e@pfizer.com
-
Neil Campbell
Senior Director, Pfizer Global Supply
n***********l@pfizer.com
-
Mathieu Poirier
Therapeutic Area Lead, Global Commercial Access Partnerships
m*************r@pfizer.com
-
Jennifer Lafontaine
VP, Head of Oncology Medicinal Chemistry
j*****************e@pfizer.com
-
Mike Mcdermott
Chief Global Supply Officer, Executive Vice President
m************t@pfizer.com
-
Sally Susman
Executive Vice President and Chief Corporate Affairs Officer
s**********n@pfizer.com
-
Kathrin Jansen
Senior Vice President and Head of Vaccine R&D
k************n@pfizer.com
-
Paul Fitzgerald
Energy, Utilities and Facilities Services Lead
p*************d@pfizer.com
-
Julie Jenson
Director Corporate Responsibility
j***********n@pfizer.com
-
Suzanna Ladas
Source to Contract Operations
s***********s@pfizer.com
-
David Breen
Site Leader, Algete, Madrid, Spain
d*********n@pfizer.com
-
Alfredo Linares
Vice President, People Experience, Organizational Development and Communications, PGS Division
a*************s@pfizer.com
-
Nooshin Rahimi
Professional Healthcare Representative
n************i@pfizer.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k***********i@pfizer.com
-
Prabhu Kundurthy
p**************y@pfizer.com
-
Steven Ph.D.
s********x@pfizer.com
-
Nina Jochnowitz
Business Analyst
n*************z@pfizer.com
-
Loucineh Mardirossian
Director, Communications
l*******************n@pfizer.com
-
Keith Jago
k********o@pfizer.com
-
Shaan Gandhi
Board Member
s**********i@pfizer.com
-
Cindy Schmidt
c***********t@pfizer.com
-
letizia greggi
l************i@pfizer.com
-
Azzurra Ravizza
a*************a@pfizer.com
-
Jane Kuczma
Director, Clinical Data Management
j*********a@pfizer.com
-
Agnes Hong
a********g@pfizer.com
-
Heather Cisek
h***********k@pfizer.com
-
Matthew Badland
m*************d@pfizer.com
-
Yulia Ivanova
y***********a@pfizer.com
-
Dario Bottaro
d***********o@pfizer.com
-
Brigitte TEXIER
b*************r@pfizer.com
-
Ron Cherepuschak
r**************k@pfizer.com
-
Johanna
j*****a@pfizer.com
-
Rasid Kamal
r*********l@pfizer.com
-
Liesbet Symoens
l*************s@pfizer.com
-
Erica Cline Reading
e***********g@pfizer.com
-
Jaclyn McNelis, MSHRM
j************s@pfizer.com
-
Christine Mckenna
Consultant
c***************a@pfizer.com
-
Juan Borger
j*********r@pfizer.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k****n@pfizer.com
-
Prabhu Kundurthy
prabhu@pfizer.com
-
General Inquiries
info@pfizer.com
HQ: Bagsværd, Hovedstaden, Denmark
Novo Nordisk
Novo Nordisk is a healthcare company that producesShow more... and distributes insulin and other diabetes drugs to treat chronic diseases.
HQ: Bagsværd, Hovedstaden, Denmark
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 27, 2024
Founded Date: 1923
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NYSE:NVO
Operating Status: Active
44 Emails
0 Phones
Main email format: sarah@novonordisk.com (90.9%)
-
Marianne Hedegaard
Service Manager (eDevice/eSolution in Clinical Trials)
c****a@novonordisk.com
-
Maziar Mike Doustdar
Executive Vice President, International Operations
m**d@novonordisk.com
-
Tony Woolard
Supervisor, Operations
t**y@novonordisk.com
-
Kasper Tarp Mortensen
Manager of Medical Affairs Excellence
k*m@novonordisk.com
-
Betina Woythal
Vice President, EA to SVP of CMC Development
b*o@novonordisk.com
-
Thomas Senderovitz
Senior Vice President Data Science
t****s@novonordisk.com
-
Liselotte Hyveled
Project Vice President, Insulin and Device
l*y@novonordisk.com
-
Steve Albers
Executive Director, Market Access
s**r@novonordisk.com
-
Jesper Hahne
Finance Partner
j**h@novonordisk.com
-
Daniel Timmermann
Head of Innovation, Global Drug Discovery
d****l@novonordisk.com
-
Jesper Lau
vice president
j**a@novonordisk.com
-
Anders Holm Mikkelsen
Head of Business Partnering Strategy Execution
a**x@novonordisk.com
-
Susan Ames
Specialist- IT Training & Communication
s**s@novonordisk.com
-
Trine Juul Wengel
t***e@novonordisk.com
-
Rasmus Holt
r****s@novonordisk.com
-
Toby Damron
Associate Director, Scientific Strategy & Alignment
t**y@novonordisk.com
-
Anna Borowiecka
Associate Director, GCP and PV Regulatory Compliance
a**a@novonordisk.com
-
Henrik Egesborg
Consultant
h****k@novonordisk.com
-
Christine Andersen
Project Director
c*******e@novonordisk.com
-
Casper Leuenhagen
c****r@novonordisk.com
-
David Flood
d***d@novonordisk.com
-
Cecilie Borregaard
c*****e@novonordisk.com
-
Lif Swaro
l*f@novonordisk.com
-
Else Marie Wollesund
e**e@novonordisk.com
-
Jitendra Maurya
SAP Technical Consultant
j******a@novonordisk.com
-
Zahra Abou Khalil
z***a@novonordisk.com
-
Nyssa Noyola
Summer Associate
n***a@novonordisk.com
-
mohamed IGHMOUR
Opéarteur polyvalent en fabrication
m*****d@novonordisk.com
-
Marcos Moreno
m****s@novonordisk.com
-
Stephanie Padilla
s*******e@novonordisk.com
-
Kanita Salic
k****a@novonordisk.com
-
Jacob de Ripperda
j***b@novonordisk.com
-
Rune Funder Hansen
r**h@novonordisk.com
-
Irene Winther
i***e@novonordisk.com
-
Carmen Sans Arija
Advisor
c****n@novonordisk.com
-
Yasar Salam Patruss
y***r@novonordisk.com
-
Jonas Andersen Helboe
j***s@novonordisk.com
-
Eva Palmqvist
e********t@novonordisk.com
-
Camilla Lenz
c*****a@novonordisk.com
-
Unclassified inbox
nnimediateam@novonordisk.com
-
Unclassified inbox
janed@novonordisk.com
-
General Inquiries
info@novonordisk.gr
-
Unclassified inbox
caio@novonordisk.com
-
Unclassified inbox
prindia@novonordisk.com
HQ: Bagsværd, Hovedstaden, Denmark
Novo Nordisk
Novo Nordisk is a healthcare company that producesShow more... and distributes insulin and other diabetes drugs to treat chronic diseases.
HQ: Bagsværd, Hovedstaden, Denmark
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Aug 30, 2024
Founded Date: 1923
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NYSE:NVO
Operating Status: Active
44 Emails
0 Phones
Main email format: sarah@novonordisk.com (90.9%)
-
Marianne Hedegaard
Service Manager (eDevice/eSolution in Clinical Trials)
c****a@novonordisk.com
-
Maziar Mike Doustdar
Executive Vice President, International Operations
m**d@novonordisk.com
-
Tony Woolard
Supervisor, Operations
t**y@novonordisk.com
-
Kasper Tarp Mortensen
Manager of Medical Affairs Excellence
k*m@novonordisk.com
-
Betina Woythal
Vice President, EA to SVP of CMC Development
b*o@novonordisk.com
-
Thomas Senderovitz
Senior Vice President Data Science
t****s@novonordisk.com
-
Liselotte Hyveled
Project Vice President, Insulin and Device
l*y@novonordisk.com
-
Steve Albers
Executive Director, Market Access
s**r@novonordisk.com
-
Jesper Hahne
Finance Partner
j**h@novonordisk.com
-
Daniel Timmermann
Head of Innovation, Global Drug Discovery
d****l@novonordisk.com
-
Jesper Lau
vice president
j**a@novonordisk.com
-
Anders Holm Mikkelsen
Head of Business Partnering Strategy Execution
a**x@novonordisk.com
-
Susan Ames
Specialist- IT Training & Communication
s**s@novonordisk.com
-
Trine Juul Wengel
t***e@novonordisk.com
-
Rasmus Holt
r****s@novonordisk.com
-
Toby Damron
Associate Director, Scientific Strategy & Alignment
t**y@novonordisk.com
-
Anna Borowiecka
Associate Director, GCP and PV Regulatory Compliance
a**a@novonordisk.com
-
Henrik Egesborg
Consultant
h****k@novonordisk.com
-
Christine Andersen
Project Director
c*******e@novonordisk.com
-
Casper Leuenhagen
c****r@novonordisk.com
-
David Flood
d***d@novonordisk.com
-
Cecilie Borregaard
c*****e@novonordisk.com
-
Lif Swaro
l*f@novonordisk.com
-
Else Marie Wollesund
e**e@novonordisk.com
-
Jitendra Maurya
SAP Technical Consultant
j******a@novonordisk.com
-
Zahra Abou Khalil
z***a@novonordisk.com
-
Nyssa Noyola
Summer Associate
n***a@novonordisk.com
-
mohamed IGHMOUR
Opéarteur polyvalent en fabrication
m*****d@novonordisk.com
-
Marcos Moreno
m****s@novonordisk.com
-
Stephanie Padilla
s*******e@novonordisk.com
-
Kanita Salic
k****a@novonordisk.com
-
Jacob de Ripperda
j***b@novonordisk.com
-
Rune Funder Hansen
r**h@novonordisk.com
-
Irene Winther
i***e@novonordisk.com
-
Carmen Sans Arija
Advisor
c****n@novonordisk.com
-
Yasar Salam Patruss
y***r@novonordisk.com
-
Jonas Andersen Helboe
j***s@novonordisk.com
-
Eva Palmqvist
e********t@novonordisk.com
-
Camilla Lenz
c*****a@novonordisk.com
-
Unclassified inbox
nnimediateam@novonordisk.com
-
Unclassified inbox
janed@novonordisk.com
-
General Inquiries
info@novonordisk.gr
-
Unclassified inbox
caio@novonordisk.com
-
Unclassified inbox
prindia@novonordisk.com
HQ: Whippany, New Jersey, United States
Bayer
Bayer is a life science company that specializes iShow more...n the areas of health care and agriculture.
HQ: Whippany, New Jersey, United States
Specialized In: Biotechnology, Manufacturing & Industrial, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Last Investment Activity: Apr 1, 2024
Founded Date: Aug 1, 1863
Number of Exits: 3
Company Type: For Profit
Stock Symbol: ETR:BAYN
Operating Status: Active
27 Emails
0 Phones
Main email format: sarah.smith@bayer.com (100.0%)
-
Annick D'haese
MA
a***********e@bayer.com
-
Christopher Yeechan
Associate Director Procurement - API & Raw Materials
c*****************n@bayer.com
-
Christian Lauterbach
Europe Region 1
c******************h@bayer.com
-
Bob Reiter
Head of Research & Development, Crop Science
b********r@bayer.com
-
Nick Canner
Executive Sales Consultant - Dermatology
n*********r@bayer.com
-
Bill Anderson
CEO-elect
b***********n@bayer.com
-
Aida Baban
Head Medical Information & Governance, Medical Affairs, Bayer Vital
a********n@bayer.com
-
Dr. Stephanie Schermuck-Joschko
Global Strategic Marketing Director
s*************************o@bayer.com
-
Joris Schreurs
Pharmacovigilance Officer
j************s@bayer.com
-
Mario Repetto
Agente Propaganda Médica
m***********o@bayer.com
-
Brigitte Gutendorf
Global Marketing Director, Commercial Lead
b****************f@bayer.com
-
Danielle Golay
Head of Quality
d************y@bayer.com
-
Alisa Reinhardt
a*************t@bayer.com
-
Jose Maria Fernandez Guerra
j*********a@bayer.com
-
Rakhshita Dhar
Venture Investments, Pharma
r************r@bayer.com
-
Derek Norman
Vice President, Venture Investments
d**********n@bayer.com
-
Kira Peikoff
Deputy Director, Communications
k**********f@bayer.com
-
Patricia Corsi
p************i@bayer.com
-
Michael Engels
Managing Director Germany / Sub-Region Head DACH
m************s@bayer.com
-
Miguel Medina
m***********a@bayer.com
-
Joris Zimmermann
j**************n@bayer.com
-
Govi Silvia
g*********a@bayer.com
-
Michael Clements
m**************s@bayer.com
-
Dawn Wysepester
d*************r@bayer.com
-
Inge De Pauw
i*********w@bayer.com
-
Pujitha Bandi
p***********i@bayer.com
-
General Inquiries
info@bayer.com
HQ: Leverkusen, Nordrhein-Westfalen, Germany
Bayer
Bayer is a life science company that specializes iShow more...n the areas of health care and agriculture.
HQ: Leverkusen, Nordrhein-Westfalen, Germany
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Grant
Last Investment Activity: Mar 28, 2024
Founded Date: Aug 1, 1863
Number of Exits: 3
Company Type: For Profit
Stock Symbol: ETR:BAYN
Operating Status: Active
29 Emails
0 Phones
Main email format: sarah.smith@bayer.com (100.0%)
-
Annick D'haese
MA
a***********e@bayer.com
-
Christopher Yeechan
Associate Director Procurement - API & Raw Materials
c*****************n@bayer.com
-
Christian Lauterbach
Europe Region 1
c******************h@bayer.com
-
Bob Reiter
Head of Research & Development, Crop Science
b********r@bayer.com
-
Nick Canner
Executive Sales Consultant - Dermatology
n*********r@bayer.com
-
Bill Anderson
CEO-elect
b***********n@bayer.com
-
Aida Baban
Head Medical Information & Governance, Medical Affairs, Bayer Vital
a********n@bayer.com
-
Dr. Stephanie Schermuck-Joschko
Global Strategic Marketing Director
s*************************o@bayer.com
-
Joris Schreurs
Pharmacovigilance Officer
j************s@bayer.com
-
Mario Repetto
Agente Propaganda Médica
m***********o@bayer.com
-
Brigitte Gutendorf
Global Marketing Director, Commercial Lead
b****************f@bayer.com
-
Danielle Golay
Head of Quality
d************y@bayer.com
-
Alisa Reinhardt
a*************t@bayer.com
-
Jose Maria Fernandez Guerra
j*********a@bayer.com
-
Rakhshita Dhar
Venture Investments, Pharma
r************r@bayer.com
-
Derek Norman
Vice President, Venture Investments
d**********n@bayer.com
-
Kira Peikoff
Deputy Director, Communications
k**********f@bayer.com
-
Patricia Corsi
p************i@bayer.com
-
Michael Engels
Managing Director Germany / Sub-Region Head DACH
m************s@bayer.com
-
Miguel Medina
m***********a@bayer.com
-
Joris Zimmermann
j**************n@bayer.com
-
Govi Silvia
g*********a@bayer.com
-
Michael Clements
m**************s@bayer.com
-
Dawn Wysepester
d*************r@bayer.com
-
Inge De Pauw
i*********w@bayer.com
-
Pujitha Bandi
p***********i@bayer.com
-
Unclassified inbox
SCIP-BAYER@bayer.com
-
General Inquiries
info@bayer.com
-
Unclassified inbox
caio.inbox@bayer.com
HQ: Whippany, New Jersey, United States
Bayer
Bayer is a life science company that specializes iShow more...n the areas of health care and agriculture.
HQ: Whippany, New Jersey, United States
Specialized In: Biotechnology, Manufacturing & Industrial, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Last Investment Activity: Apr 1, 2024
Founded Date: Aug 1, 1863
Number of Exits: 3
Company Type: For Profit
Stock Symbol: ETR:BAYN
Operating Status: Active
27 Emails
0 Phones
Main email format: sarah.smith@bayer.com (100.0%)
-
Annick D'haese
MA
a***********e@bayer.com
-
Christopher Yeechan
Associate Director Procurement - API & Raw Materials
c*****************n@bayer.com
-
Christian Lauterbach
Europe Region 1
c******************h@bayer.com
-
Bob Reiter
Head of Research & Development, Crop Science
b********r@bayer.com
-
Nick Canner
Executive Sales Consultant - Dermatology
n*********r@bayer.com
-
Bill Anderson
CEO-elect
b***********n@bayer.com
-
Aida Baban
Head Medical Information & Governance, Medical Affairs, Bayer Vital
a********n@bayer.com
-
Dr. Stephanie Schermuck-Joschko
Global Strategic Marketing Director
s*************************o@bayer.com
-
Joris Schreurs
Pharmacovigilance Officer
j************s@bayer.com
-
Mario Repetto
Agente Propaganda Médica
m***********o@bayer.com
-
Brigitte Gutendorf
Global Marketing Director, Commercial Lead
b****************f@bayer.com
-
Danielle Golay
Head of Quality
d************y@bayer.com
-
Alisa Reinhardt
a*************t@bayer.com
-
Jose Maria Fernandez Guerra
j*********a@bayer.com
-
Rakhshita Dhar
Venture Investments, Pharma
r************r@bayer.com
-
Derek Norman
Vice President, Venture Investments
d**********n@bayer.com
-
Kira Peikoff
Deputy Director, Communications
k**********f@bayer.com
-
Patricia Corsi
p************i@bayer.com
-
Michael Engels
Managing Director Germany / Sub-Region Head DACH
m************s@bayer.com
-
Miguel Medina
m***********a@bayer.com
-
Joris Zimmermann
j**************n@bayer.com
-
Govi Silvia
g*********a@bayer.com
-
Michael Clements
m**************s@bayer.com
-
Dawn Wysepester
d*************r@bayer.com
-
Inge De Pauw
i*********w@bayer.com
-
Pujitha Bandi
p***********i@bayer.com
-
General Inquiries
info@bayer.com
HQ: Cambridge, Cambridgeshire, United Kingdom
AstraZeneca
AstraZeneca is a pharmaceutical company that discoShow more...vers, develops, manufactures, and markets prescription medicines.
HQ: Cambridge, Cambridgeshire, United Kingdom
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 23, 2024
Founded Date: Apr 6, 1999
Number of Exits: 11
Company Type: For Profit
Stock Symbol: NSE:ASTRAZEN
Operating Status: Active
27 Emails
0 Phones
Main email format: sarah.smith@astrazeneca.com (100.0%)
-
Marc Dunoyer
Chief Strategy Officer
m**********r@astrazeneca.com
-
Richard Gallo
Oncology Contract Strategy Manager
r***********o@astrazeneca.com
-
Nabil Dharsi
Medical Science Liaison, Hematology
n**********i@astrazeneca.com
-
Dan Wygal
Executive Director of Contract and Channel Strategy
d*******l@astrazeneca.com
-
Claudia Lamp
Contract Sr Patient Safety Scientist
c**********p@astrazeneca.com
-
Tom Keith-Roach
President, Astrazeneca UK
t*************h@astrazeneca.com
-
Mary Richardson
Global Publications Director, OBU
m*************n@astrazeneca.com
-
Matthew Roe
VP, Head of Early Clinical Development - Cardiovascular, Renal, and Metabolic
m*********e@astrazeneca.com
-
Jennifer Schmoll
Global Marketing Director-Diabetes
j**************l@astrazeneca.com
-
Lee Bennett
Associate Regulatory Project Director
l*********t@astrazeneca.com
-
Jasmine Jansens
Clinical Site Monitor
j*************s@astrazeneca.com
-
Stephanie Kenney
Global Head of Corporate Affairs, Cardiovascular Renal and Metabolism
s********************i@astrazeneca.com
-
Giovanni Melillo
Vice President - Immuno-oncology, Global Medical Affairs
g**************o@astrazeneca.com
-
Karina Estevez
Human Resources Global Graduate Associate
k************z@astrazeneca.com
-
Francesco Dazzi
Professor of Regenerative and Haematological Medicine - KHP Lead for Cellular Therapies
f*************i@astrazeneca.com
-
Graham Belfield
g*************d@astrazeneca.com
-
Tony Pusic
t********c@astrazeneca.com
-
Ronnie Stevens
r************s@astrazeneca.com
-
Miriam Wu
m*******u@astrazeneca.com
-
James Thomas Coates
Principal
j**********s@astrazeneca.com
-
Chandler Chen
Investment Director, Healthcare Fund
c***********n@astrazeneca.com
-
Jelena Saillard
j*************d@astrazeneca.com
-
Debasree Purkayastha
d******************a@astrazeneca.com
-
Shameen Afif-Rider
s****************r@astrazeneca.com
-
Wilbur Washington
Oncology Senior Sales Specialist - Hematology/Solid Tumor
w***************n@astrazeneca.com
-
General Inquiries
contact@astrazeneca.com
-
General Inquiries
help@astrazeneca.com
HQ: Basel, Basel-Stadt, Switzerland
Roche
Roche is a pharmaceutical and diagnostics company Show more...that focuses on improving people’s lives.
HQ: Basel, Basel-Stadt, Switzerland
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 27, 2024
Founded Date: Jan 15, 1896
Number of Exits: 3
Company Type: For Profit
Stock Symbol: SWX:ROG
Operating Status: Active
30 Emails
0 Phones
Main email format: sarah.smith@roche.com (100.0%)
-
Jason Hall
Senior Business Analyst
j********l@roche.com
-
Thomas Schinecker
t***************r@roche.com
-
Brad Moore
b********e@roche.com
-
Andre Hoffmann
a************n@roche.com
-
Darla Ramsey
d**********p@roche.com
-
Kevin Bylinski
k************i@roche.com
-
Abed Sabra
a********a@roche.com
-
Nikolce Gjorevski
n***************i@roche.com
-
David Barton
d********1@roche.com
-
Mark Adam
m*******m@roche.com
-
Andrzej Dobrowolski
a*****************i@roche.com
-
Tristin Martin
t************n@roche.com
-
Ivana Vodopivec
i*************c@roche.com
-
William Fraser
w************r@roche.com
-
Björn Itrich
b*********h@roche.com
-
Martin Erschbamer
m***************r@roche.com
-
Anand Vairavan
a************n@roche.com
-
Tim Kuruvilla
Investment Associate
t***********a@roche.com
-
Sanju Sudhakar
s************r@roche.com
-
Szymon Arkuszewski
s****************i@roche.com
-
Mattia Giobbi
m***********i@roche.com
-
Krzysztof Wisniewski
k******************i@roche.com
-
Judy Ney
j******y@roche.com
-
Unclassified inbox
patientcare@roche.com
-
Unclassified inbox
new_zealand.dia_communications@roche.com
-
Unclassified inbox
ireland.drug_surveillance_centre@roche.com
-
General Inquiries
illovo.medinfo@roche.com
-
Unclassified inbox
joerg.kazenwadel@roche.com
-
Unclassified inbox
klaus.christensen@roche.com
-
General Inquiries
mississauga.canada_medinfo@roche.com
HQ: New York, New York, United States
Bristol-Myers Squibb
Bristol-Myers Squibb engages in the discovery, devShow more...elopment, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals.
HQ: New York, New York, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 28, 2024
Founded Date: 1887
Number of Exits: 14
Company Type: For Profit
Stock Symbol: NYSE:BMY
Operating Status: Active
Investor Type: Venture Capital
26 Emails
0 Phones
Main email format: sarah.smith@bms.com (95.2%)
-
John damonti
Foundation President
d******j@bms.com
-
Ron Behling
r************g@bms.com
-
Devin Carsdale
d************e@bms.com
-
Suketu Desai
s**********i@bms.com
-
Zelalem Demere
z************e@bms.com
-
Eva Dion
e******n@bms.com
-
Dina Akbar
d********r@bms.com
-
Jaya Saigal
j*********l@bms.com
-
Danish Sheikh
d***********h@bms.com
-
Trisha Putro
t**********o@bms.com
-
Xue Li
x****i@bms.com
-
Gianina Meltzer
Senior Manager, Regulatory Affairs (Oncology)
g*************r@bms.com
-
Zachary Cain
Associate Director, Payer Marketing at Bristol-Myers Squibb
z**********n@bms.com
-
Zheng Yang
Scientist
z********g@bms.com
-
Herve Bertacchi
h*************i@bms.com
-
Ming Lu
Vice President Clinical Pharmacology
m*****u@bms.com
-
Sonja Heintz
s**********z@bms.com
-
Torsten Schanze
t*************e@bms.com
-
Patricia Gaul
p***********l@bms.com
-
Vanessa Mariani
v****************a@bms.com
-
Emmanuel Chantelot
e****************t@bms.com
-
Ha Dang
h*****g@bms.com
-
Maribelis Ruiz
m************z@bms.com
-
General Inquiries
hello@bms.com
-
General Inquiries
contact@bms.com
-
Legal Department
legal@bms.com
HQ: London, England, United Kingdom
Johnson Matthey
Johnson Matthey is an international speciality cheShow more...micals company, founded almost 200 years ago in London.
HQ: London, England, United Kingdom
Specialized In: Manufacturing & Industrial, Technology & Software, Pharmaceuticals, Staffing Agencies
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 20, 2024
Founded Date: 1817
Number of Exits: 1
Company Type: For Profit
Stock Symbol: LSE:JMPLF
Operating Status: Active
26 Emails
0 Phones
Main email format: sarah.smith@matthey.com (89.5%)
-
Margaret Ruiseal
Global HR Transformation Director
m**************l@matthey.com
-
Erwin Teirlinck
Business Development Manager
e*************k@matthey.com
-
Kendra Briggs
Sales Manager
k*********g@matthey.com
-
Anca Faur
Program Manager, Fuel Cells
a*******r@matthey.com
-
Janet Lung Standing
Global Procurement Director - Indirects
j************g@matthey.com
-
Emilie Pijls
Director Global Procurement - Sector Clean Air
e**********s@matthey.com
-
Akshay Kolte
Program Manager
a**********e@matthey.com
-
Florin Filipas
Sr. Process Engineer
f************s@matthey.com
-
David Colomina
ITIL Instructor
d************a@matthey.com
-
Sharmila Thirumalai
Technical Recruiter
s*****************i@matthey.com
-
Ekaterina Novakova
Market Manager Purification
e****************a@matthey.com
-
Aaron Bloomfield
Research And Development Scientist
a**************d@matthey.com
-
Rebecca Lawman
Marketing Director
r************n@matthey.com
-
David Nguyen
Human-centered Innovator/Entrepreneur/Researcher
n*****d@matthey.com
-
Ryan Mitstifer
Global Operational Excellence Leader
r************r@matthey.com
-
Jonathan Mccreegrey
Hydrogen Technologies Recycling Manager
jm@matthey.com
-
Joe Fox
Finance Transformation Director
j*****x@matthey.com
-
Randy Lerch
Night Shift Maintenance Supervisor
r*********h@matthey.com
-
Harry Deans
EHS & Operations Officer
h*********s@matthey.com
-
Karen Hayzen-Smith
Director of Group Finance
k****************h@matthey.com
-
Benedicte Thiebaut
Technology Director of Medical Components
b****************t@matthey.com
-
Percival Norton Johnson
Founder
j*****n@matthey.com
-
Unclassified inbox
elmar.braeuning@matthey.com
-
Unclassified inbox
mj@matthey.com
-
General Inquiries
group.info@matthey.com
-
Unclassified inbox
jmpr@matthey.com
HQ: Brentford, Hounslow, United Kingdom
GSK
GSK manufactures pharmaceutical medicines, vaccineShow more...s, and consumer healthcare products.
HQ: Brentford, Hounslow, United Kingdom
Specialized In: Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 10001+
Last Investment Activity: Aug 20, 2024
Founded Date: Jan 2000
Company Type: For Profit
Stock Symbol: BOM:500660
Operating Status: Active
22 Emails
0 Phones
Main email format: sarah.smith@gsk.com (93.8%)
-
Magnus Hibbert
m************t@gsk.com
-
Warren Carin
w**********n@gsk.com
-
Philip Thomson
p**************n@gsk.com
-
Fernando Bruni
f************i@gsk.com
-
Bill Sass
b*******s@gsk.com
-
Heinz Doofenshmirtz
h*****************z@gsk.com
-
Lydie Georges
l***********s@gsk.com
-
Alex Benn
a*******n@gsk.com
-
Regis Simard
r**********d@gsk.com
-
Darwin Johnston
d*************n@gsk.com
-
Warren Carin
w************n@gsk.com
-
Leigh Baker
l*********r@gsk.com
-
Jessica Beacham
j*************m@gsk.com
-
Yusuf Karagöz
u************z@gsk.com
-
Agnieszka Kowalczyk
a*****************k@gsk.com
-
Nathalie LORET-MAHE
n**************t@gsk.com
-
Jean-Christophe Goirand
j********************d@gsk.com
-
Kirill Nikitin
k************n@gsk.com
-
Vibhu Gupta
v*********a@gsk.com
-
Marine Anciaux
Internship - Emulsion Development Group
m***********x@gsk.com
-
Jeremy England
j************d@gsk.com
-
Unclassified inbox
askus@gsk.com
HQ: London, England, United Kingdom
GlaxoSmithKline
GlaxoSmithKline develops and markets products in tShow more...he areas of pain relief, respiratory, digestive health, oral health, nutrition and skin.
HQ: London, England, United Kingdom
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Grant
Last Investment Activity: Mar 1, 2024
Founded Date: 1929
Number of Exits: 14
Company Type: For Profit
Stock Symbol: NYSE:GSK
Operating Status: Active
25 Emails
0 Phones
Main email format: sarah.smith@gsk.com (93.8%)
-
Magnus Hibbert
m************t@gsk.com
-
Warren Carin
w**********n@gsk.com
-
Philip Thomson
p**************n@gsk.com
-
Fernando Bruni
f************i@gsk.com
-
Bill Sass
b*******s@gsk.com
-
Heinz Doofenshmirtz
h*****************z@gsk.com
-
Lydie Georges
l***********s@gsk.com
-
Alex Benn
a*******n@gsk.com
-
Regis Simard
r**********d@gsk.com
-
Darwin Johnston
d*************n@gsk.com
-
Warren Carin
w************n@gsk.com
-
Leigh Baker
l*********r@gsk.com
-
Jessica Beacham
j*************m@gsk.com
-
Yusuf Karagöz
u************z@gsk.com
-
Agnieszka Kowalczyk
a*****************k@gsk.com
-
Nathalie LORET-MAHE
n**************t@gsk.com
-
Jean-Christophe Goirand
j********************d@gsk.com
-
Kirill Nikitin
k************n@gsk.com
-
Vibhu Gupta
v*********a@gsk.com
-
Marine Anciaux
Internship - Emulsion Development Group
m***********x@gsk.com
-
Jeremy England
j************d@gsk.com
-
General Inquiries
info@gsk.com
-
Customer Service
support@gsk.com
-
Sales Department
sales@gsk.com
-
Unclassified inbox
Simon.M.Bicknell@gsk.com
HQ: Brentford, Hounslow, United Kingdom
GSK
GSK manufactures pharmaceutical medicines, vaccineShow more...s, and consumer healthcare products.
HQ: Brentford, Hounslow, United Kingdom
Specialized In: Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 10001+
Last Investment Activity: Aug 20, 2024
Founded Date: Jan 2000
Company Type: For Profit
Stock Symbol: BOM:500660
Operating Status: Active
22 Emails
0 Phones
Main email format: sarah.smith@gsk.com (93.8%)
-
Magnus Hibbert
m************t@gsk.com
-
Warren Carin
w**********n@gsk.com
-
Philip Thomson
p**************n@gsk.com
-
Fernando Bruni
f************i@gsk.com
-
Bill Sass
b*******s@gsk.com
-
Heinz Doofenshmirtz
h*****************z@gsk.com
-
Lydie Georges
l***********s@gsk.com
-
Alex Benn
a*******n@gsk.com
-
Regis Simard
r**********d@gsk.com
-
Darwin Johnston
d*************n@gsk.com
-
Warren Carin
w************n@gsk.com
-
Leigh Baker
l*********r@gsk.com
-
Jessica Beacham
j*************m@gsk.com
-
Yusuf Karagöz
u************z@gsk.com
-
Agnieszka Kowalczyk
a*****************k@gsk.com
-
Nathalie LORET-MAHE
n**************t@gsk.com
-
Jean-Christophe Goirand
j********************d@gsk.com
-
Kirill Nikitin
k************n@gsk.com
-
Vibhu Gupta
v*********a@gsk.com
-
Marine Anciaux
Internship - Emulsion Development Group
m***********x@gsk.com
-
Jeremy England
j************d@gsk.com
-
Unclassified inbox
askus@gsk.com
HQ: San Francisco, California, United States
University of California, San Francisco
Director of the Lab for Advanced Cytometry (LAC) aShow more...nd the Sony Biotechnology Center at UCSF in the Department of Laboratory Medicine
HQ: San Francisco, California, United States
Specialized In: Biotechnology, Education & E-learning, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Rounds: Grant
Last Investment Activity: Nov 21, 2023
Founded Date: 1873
Company Type: For Profit
Operating Status: Active
21 Emails
0 Phones
Main email format: sarah.smith@ucsf.edu (100.0%)
-
Judy Kim
j******m@ucsf.edu
-
Sunita Mutha
Professor of Medicine
s**********a@ucsf.edu
-
Danilo Bernardo
d*************o@ucsf.edu
-
Fred Schaufele
f************e@ucsf.edu
-
Susanna Chau
s**********u@ucsf.edu
-
Butsina Wanjala
b*************a@ucsf.edu
-
Lori Luo
MD/PhD Student
l******o@ucsf.edu
-
Michael Lavelle
m*************e@ucsf.edu
-
Christopher Stewart
c***********t@ucsf.edu
-
Jiyong Ahn
j********n@ucsf.edu
-
Peng Cong
Professor and Director of Brain Interface Technology
p*******g@ucsf.edu
-
Coralie Trentesaux
c****************x@ucsf.edu
-
Leonard Telesca
l*************a@ucsf.edu
-
Suraj Rajan
s*********n@ucsf.edu
-
Martha Ockenfelsmartinez
m**********************z@ucsf.edu
-
Nam Woo Cho
n*****o@ucsf.edu
-
Gwendolyn Lee
g***********e@ucsf.edu
-
Monica Getahun
m************n@ucsf.edu
-
Srikar Kollipara
s**************a@ucsf.edu
-
Amy Penn
a******n@ucsf.edu
-
Media Relations
socialmedia@ucsf.edu
HQ: San Francisco, California, United States
University of California, San Francisco
Director of the Lab for Advanced Cytometry (LAC) aShow more...nd the Sony Biotechnology Center at UCSF in the Department of Laboratory Medicine
HQ: San Francisco, California, United States
Specialized In: Biotechnology, Education & E-learning, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Rounds: Grant
Last Investment Activity: Nov 21, 2023
Founded Date: 1873
Company Type: For Profit
Operating Status: Active
21 Emails
0 Phones
Main email format: sarah.smith@ucsf.edu (100.0%)
-
Judy Kim
j******m@ucsf.edu
-
Sunita Mutha
Professor of Medicine
s**********a@ucsf.edu
-
Danilo Bernardo
d*************o@ucsf.edu
-
Fred Schaufele
f************e@ucsf.edu
-
Susanna Chau
s**********u@ucsf.edu
-
Butsina Wanjala
b*************a@ucsf.edu
-
Lori Luo
MD/PhD Student
l******o@ucsf.edu
-
Michael Lavelle
m*************e@ucsf.edu
-
Christopher Stewart
c***********t@ucsf.edu
-
Jiyong Ahn
j********n@ucsf.edu
-
Peng Cong
Professor and Director of Brain Interface Technology
p*******g@ucsf.edu
-
Coralie Trentesaux
c****************x@ucsf.edu
-
Leonard Telesca
l*************a@ucsf.edu
-
Suraj Rajan
s*********n@ucsf.edu
-
Martha Ockenfelsmartinez
m**********************z@ucsf.edu
-
Nam Woo Cho
n*****o@ucsf.edu
-
Gwendolyn Lee
g***********e@ucsf.edu
-
Monica Getahun
m************n@ucsf.edu
-
Srikar Kollipara
s**************a@ucsf.edu
-
Amy Penn
a******n@ucsf.edu
-
Media Relations
socialmedia@ucsf.edu
HQ: Thousand Oaks, California, United States
Amgen
Amgen is a biotechnology company that develops andShow more... manufactures human therapeutics for various illnesses and diseases.
HQ: Thousand Oaks, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 21, 2024
Founded Date: 1980
Number of Exits: 8
Company Type: For Profit
Stock Symbol: NASDAQ:AMGN
Operating Status: Active
22 Emails
0 Phones
Main email format: ssmith@amgen.com (88.9%)
-
Esteban Santos
Executive Vice President, Operations
e******s@amgen.com
-
Bob Bradway
Chief Executive Officer
b******y@amgen.com
-
Angelina Finch
Marketing Director, U.S. Value & Access
a****h@amgen.com
-
Jack Ryan
Operations Manager
j***n@amgen.com
-
Gladys Nunez
Director
g**********z@amgen.com
-
Gladys Nunez
Director
g****z@amgen.com
-
Kathrine Parrish
Patient Access and Reimbursement Manager
k******h@amgen.com
-
Chen Xiaoyue
Post doctoral research fellow in Oncology department
c******e@amgen.com
-
Rosalyn Rivera
Director, Contract Manufacturing
r*****a@amgen.com
-
Nicola Magill
Senior Manager / Principal Engineer
n*****l@amgen.com
-
Sheela Kotagiri
Project Manager
s*******i@amgen.com
-
Ingrid Darmody
Senior Associate QA
i******y@amgen.com
-
Sergio Rodriguez Mallada
QA Specialist
s******a@amgen.com
-
Wendy Kusler
w*****r@amgen.com
-
Krupali Patel
k****l@amgen.com
-
Susan Sweeney
s******y@amgen.com
-
Angelinda Chen
Gender Lens Impact Investing Fellow
a***n@amgen.com
-
Daniel Lu
d*u@amgen.com
-
Rex Atienza
r******a@amgen.com
-
Unclassified inbox
HCCIME@amgen.com
-
Unclassified inbox
medinfocanada@amgen.com
-
Unclassified inbox
amgenmediarelations@amgen.com
HQ: Foster City, California, United States
Gilead Sciences
Gilead Sciences is a biopharmaceutical company thaShow more...t discovers, develops, manufactures and commercializes therapies for critical diseases.
HQ: Foster City, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Manufacturing & Industrial
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 28, 2024
Founded Date: Jun 22, 1987
Number of Exits: 16
Company Type: For Profit
Stock Symbol: BIT:GILD
Operating Status: Active
20 Emails
2 Phones
Main email format: sarah.smith@gilead.com (82.4%)
-
Ahmed Afifi
Vice President - Region Head Latin America
a*********i@gilead.com
-
Kelsey Reedy
Talent Advisor
k**********y@gilead.com
-
Anhquan Nguyen
Senior Research Associate
a*****n@gilead.com
-
Jack Wessel
Associate General Counsel, IP
j*********l@gilead.com
-
Patrick Loerch
Senior Vice President, Clinical Data Science
p*****h@gilead.com
-
Rashad Burgess
Regional Sales Director
r************s@gilead.com
-
Brian Peters
Senior Director, Procurement
f*****n@gilead.com
-
Don Dennis
Director
d********s@gilead.com
-
Elysia K
Sr. Clinical Trial Management Associate
e******k@gilead.com
-
Merdad Parsey
EVP & CMO Gilead Sciences
m*****y@gilead.com
-
Stacey Ma
Executive Vice President, Pharmaceutical Development and Manufacturing,
m**********h@gilead.com
-
Ketki Malgaonkar
Regulatory Affairs Manager
k**************r@gilead.com
-
Abhishek Bachchan
a***************n@gilead.com
-
Yin Jonkman
Compensation and Benefits Manager EMEA a.i
y*********n@gilead.com
-
Ethan Grant
e*********t@gilead.com
-
Karim Lee
k*******e@gilead.com
-
Angie Hertz
a*********z@gilead.com
-
Fatima Farid
f**********d@gilead.com
-
Nara Ramakrishnan
n***************n@gilead.com
-
Unclassified inbox
public_affairs@gilead.com
HQ: Durham, North Carolina, United States
Quintiles
Quintiles is a provider of biopharmaceutical develShow more...opment and commercial outsourcing services for drugs on the market.
HQ: Durham, North Carolina, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Acquired by: IMS Health
Business Type: Delisted
Employees: 10001+
Rounds: Grant
Last Investment Activity: Jan 22, 2024
Founded Date: 1982
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:Q
Operating Status: Active
18 Emails
2 Phones
Main email format: sarah.smith@quintiles.com (100.0%)
-
Saida El Maslouhi, MSc.
Director Early Clinical Development
s**************i@quintiles.com
-
Darren Coish
d**********h@quintiles.com
-
Kimmy Yang
Senior Clinical Research Associate
k********g@quintiles.com
-
Priya Gamre
Assistant Medical Data Review Manager
p*********e@quintiles.com
-
Lucia Novoa
Clinical Team Leader
l*********a@quintiles.com
-
Aisha Keller
a**********r@quintiles.com
-
Brian Kelly
Senior Advisor
p************k@quintiles.com
-
Jara Soltero
j**********o@quintiles.com
-
Hicham Benhaddi
h*************i@quintiles.com
-
Alistair Grenfell
President North Europe, Middle East, Africa and South Asia
a***************l@quintiles.com
-
Diane Brescia
Sr. Recruiter
d***********a@quintiles.com
-
Parag Phad
p********d@quintiles.com
-
Michelle Wilken
Director of Commercial Strategy
m*************n@quintiles.com
-
Jeff Fusco
j********o@quintiles.com
-
Cindy Lam
c*******m@quintiles.com
-
Patrick Daly
Executive In Residence
p**********y@quintiles.com
-
Debalina Pani
d***********i@quintiles.com
-
Fatemeh Tahavori
fatemeh.tahavori@quintiles.com
-
General Inquiries
info@quintiles.com
HQ: Cambridge, Massachusetts, United States
Moderna
Moderna Therapeutics is a biotechnology company thShow more...at specializes in drug discovery and drug development based on messenger RNA.
HQ: Cambridge, Massachusetts, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 15, 2024
Founded Date: 2010
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NASDAQ:MRNA
Operating Status: Active
Investor Type: Investment Bank
20 Emails
3 Phones
Main email format: sarah.smith@modernatx.com (100.0%)
-
Huijuan Li
Head, Analytical Development
h********i@modernatx.com
-
Kerry Salandria
Associate Director, Analytical Operations
k*************a@modernatx.com
-
Dean Geribo
Head of Corporate Security
d*********o@modernatx.com
-
Michael Wythe
Senior Director
m***********e@modernatx.com
-
Spyros Chalkias
Senior Medical Director, Clinical Development, Infectious Disease - Public Health Vaccines
s*************s@modernatx.com
-
Galit Alter
VP of Immunology Research
g*********r@modernatx.com
-
Tina Earl
Sr. Specialist, Quality Assurance
t*******l@modernatx.com
-
Francesca Ceddia
SVP Respiratory Vaccines, Global Medical
f**************a@modernatx.com
-
Lilly Naqvi
Engineer II
l*********i@modernatx.com
-
Seymour De Picciotto
Scientific Director
s*****************o@modernatx.com
-
Tatiana Novobrantseva
Chief Scientific Officer, Immuno-Oncology Research
t*******************a@modernatx.com
-
Juan Andres
Senior Vice President Technical Development, Manufacturing and Quality
j*********s@modernatx.com
-
Juan Andres
Senior Vice President Technical Development, Manufacturing and Quality
s***********y@modernatx.com
-
Nidal El Assi
Associate Director Of Lab Operations
n********i@modernatx.com
-
Lavina Talukdar
l*************r@modernatx.com
-
Shannon Thyme Klinger
Chief Legal Officer at Moderna
s*************r@modernatx.com
-
Gamal Elfatarany
g**************y@modernatx.com
-
Unclassified inbox
WeCare@modernatx.com
-
Unclassified inbox
Grace.Chen@modernatx.com
-
General Inquiries
info@modernatx.com
HQ: Indianapolis, Indiana, United States
Eli Lilly
Eli Lilly engages in the discovery, development, mShow more...anufacture, and sale of pharmaceutical products.
HQ: Indianapolis, Indiana, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Jul 8, 2024
Founded Date: Jan 1, 1876
Number of Exits: 22
Company Type: For Profit
Stock Symbol: EPA:LLY
Operating Status: Active
17 Emails
0 Phones
Main email format: sarah.smith@lilly.com (50.0%)
-
Marie Murphy
Principal Research Scientist, Technical Services Manufacturing Network
mm@lilly.com
-
Sean Glennon
Director, International Business Unit Procurement at Eli Lilly and Company
g**********n@lilly.com
-
Ricardo Samms
Senior Research Scientist
s***********o@lilly.com
-
Paolo Romiti
Site Services Sr. Manager
r**********o@lilly.com
-
Cormac Gorman
Medical Sales Representative
g***********c@lilly.com
-
Maurizio Guidi
sr director Medical Affairs Capabilities and Opearation for ACE ( Australia, Canada, Europe)
g************o@lilly.com
-
Ann Connery
Vice President Quality - Drug Product Operations America/ Asia
c*********n@lilly.com
-
Devrim Dirik
Marketing Director
d**********m@lilly.com
-
Zhanglin Cui
Research Advisor
c**********n@lilly.com
-
Edgardo Hernandez
Sr. Vice President, Drug Product Manufacturing
h***************o@lilly.com
-
Tyron Johnson
Clinical Development Consultant
j***********n@lilly.com
-
Violaine Huck
h***********e@lilly.com
-
Anindya Sen
Director at Prevail Therapeutics
s*********a@lilly.com
-
Jessica Witherow
Autoimmune and Rare Disease Specialist
w**************a@lilly.com
-
Gary J Gacek
g********k@lilly.com
-
Lotus Mallbris
l************s@lilly.com
-
Halle Bull
Pharmaceutical Sales Consultant
bull_halle@lilly.com
-
General Inquiries
info@lilly.com
HQ: Indianapolis, Indiana, United States
Eli Lilly
Eli Lilly engages in the discovery, development, mShow more...anufacture, and sale of pharmaceutical products.
HQ: Indianapolis, Indiana, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 6, 2024
Founded Date: Jan 1, 1876
Number of Exits: 22
Company Type: For Profit
Stock Symbol: EPA:LLY
Operating Status: Active
17 Emails
0 Phones
Main email format: sarah.smith@lilly.com (50.0%)
-
Marie Murphy
Principal Research Scientist, Technical Services Manufacturing Network
mm@lilly.com
-
Sean Glennon
Director, International Business Unit Procurement at Eli Lilly and Company
g**********n@lilly.com
-
Ricardo Samms
Senior Research Scientist
s***********o@lilly.com
-
Paolo Romiti
Site Services Sr. Manager
r**********o@lilly.com
-
Cormac Gorman
Medical Sales Representative
g***********c@lilly.com
-
Maurizio Guidi
sr director Medical Affairs Capabilities and Opearation for ACE ( Australia, Canada, Europe)
g************o@lilly.com
-
Ann Connery
Vice President Quality - Drug Product Operations America/ Asia
c*********n@lilly.com
-
Devrim Dirik
Marketing Director
d**********m@lilly.com
-
Zhanglin Cui
Research Advisor
c**********n@lilly.com
-
Edgardo Hernandez
Sr. Vice President, Drug Product Manufacturing
h***************o@lilly.com
-
Tyron Johnson
Clinical Development Consultant
j***********n@lilly.com
-
Violaine Huck
h***********e@lilly.com
-
Anindya Sen
Director at Prevail Therapeutics
s*********a@lilly.com
-
Jessica Witherow
Autoimmune and Rare Disease Specialist
w**************a@lilly.com
-
Gary J Gacek
g********k@lilly.com
-
Lotus Mallbris
l************s@lilly.com
-
Halle Bull
Pharmaceutical Sales Consultant
bull_halle@lilly.com
-
General Inquiries
info@lilly.com
HQ: Boston, Massachusetts, United States
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discoveryShow more... and development of small molecule drugs for the treatment of serious diseases.
HQ: Boston, Massachusetts, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 1, 2024
Founded Date: 1989
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:VRTX
Operating Status: Active
17 Emails
0 Phones
Main email format: sarah_smith@vrtx.com (64.3%)
-
Thomas Carney
Manager (GMP facility focus), Project Management Office, Global Capital Project Management
t***********y@vrtx.com
-
Gillian
Vice President, Strategic Operations, Regulatory Affairs and Quality
g@vrtx.com
-
Reshma Kewalramani
CEO and President
r****************i@vrtx.com
-
Javier Coindreau
VP Global Strategy Lead - Medical Affairs
j**************u@vrtx.com
-
Uma Raut
Director Global Regulatory Affairs, Cell and Gene Therapy
u******t@vrtx.com
-
Michele Bellandi
Vice President International Commercial
m**************i@vrtx.com
-
Elena Minichiello
Associate Director, Market Access Strategy and Planning
e***************o@vrtx.com
-
Rabah Chibane
Operations Supervisor
r***********e@vrtx.com
-
Robin Bean
Site Activation Manager
r********n@vrtx.com
-
Joshua Chen
VP Biostatistics
j*s@vrtx.com
-
Mark Yu
Senior Research Associate
m*****u@vrtx.com
-
Isaac Vasanthkumar
i****************r@vrtx.com
-
Guoxiang Ruan
g***********n@vrtx.com
-
Phillip Snyder
p************r@vrtx.com
-
Mac Johnson
Senior Director, Research, Vertex Pharmaceuticals
m*********n@vrtx.com
-
Morrey Atkinson
m*************n@vrtx.com
-
General Inquiries
mediainfo@vrtx.com
HQ: Tel Aviv, Tel Aviv, Israel
Teva Pharmaceuticals
Teva Pharmaceuticals is a pharmaceutical company tShow more...hat develops generic and innovative medicines.
HQ: Tel Aviv, Tel Aviv, Israel
Specialized In: Pharmaceuticals, Healthcare & Medical
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Feb 12, 2024
Founded Date: 1901
Number of Exits: 8
Company Type: For Profit
Stock Symbol: NYSE:TEVA
Operating Status: Active
16 Emails
0 Phones
Main email format: sarah.smith@tevapharm.com (58.3%)
-
Rob Koremans
President and CEO, Global Specialty Medicines
r*********s@tevapharm.com
-
Kathleen Veit
Vice President, Global Compliance & Ethics Operations & Investigations
k***********t@tevapharm.com
-
Aneta Filik
HR Director
a*********k@tevapharm.com
-
Kim Peetz
CFO Scandinavia
k*******z@tevapharm.com
-
Jacob Killian
Microbiologist III (Quality Control Analyst II)
j***********n@tevapharm.com
-
Sarah Cross
Senior Sales Specialist
s*********s@tevapharm.com
-
Danny Mcbryan
Senior Vice President, Head of Global Medical Affairs And Pharmacovigilance
d***********n@tevapharm.com
-
Melanie Nano Entena
Director, New Product Strategy - Respiratory
m************a@tevapharm.com
-
Zeno Ordan
Associate Director Total Rewards, Southern Europe
z********n@tevapharm.com
-
Anthony Dombrowski Cmr
Neurology Account Specialist
a*********r@tevapharm.com
-
Joost Cohen Tervaert
Advisory Board Member at Sanara Ventures
j************t@tevapharm.com
-
Brandon Goodman
Associate Director, Commercial Training at Blueprint Medicines
b*****n@tevapharm.com
-
Jim Stice
Professor
j*m@tevapharm.com
-
Tim Buchanan
Sales Director
t*m@tevapharm.com
-
Alicia Roeschke
Customer Enablement Manager at Grainger
a****a@tevapharm.com
-
Unclassified inbox
jobs.europe@tevaeu.com
HQ: Basel, Basel-Stadt, Switzerland
Lonza
Lonza Group supplies products and services to pharShow more...maceutical and agrochemical industries.
HQ: Basel, Basel-Stadt, Switzerland
Specialized In: Biotechnology, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 22, 2024
Founded Date: 1897
Number of Exits: 1
Company Type: For Profit
Stock Symbol: SWX:LONN
Operating Status: Active
17 Emails
0 Phones
Main email format: sarah.smith@lonza.com (100.0%)
-
Alice Harrison
Global Technical Director
a************n@lonza.com
-
Wolfgang D)
global Project Manager (Master Black Belt)
w***********k@lonza.com
-
Matthew Hall
Western Regional Sales Manager
m**********l@lonza.com
-
Donald Sohn, CFA
d*********n@lonza.com
-
Paul Tastenhoye
Program Management Leader Peptides/Braine
p*************e@lonza.com
-
Peter Aken
Global Head of Antifouling Paints and Aquaculture
p***********n@lonza.com
-
Klea Lenja
k********a@lonza.com
-
Peter Groenewege
Director Innovation Strategy & PMO (Capsules & Health ingredients)
p**************e@lonza.com
-
Eric Blomgren
Associate Director, Business Development
e***********n@lonza.com
-
Cameron Kadleck
Scientist
c*************k@lonza.com
-
Chris Maskell
Head Of Program Management
c***********l@lonza.com
-
Thomas Stuenkel
t*************l@lonza.com
-
Elissa Goldstein
e**************n@lonza.com
-
Wolfgang Zimmerer
z***************g@lonza.com
-
General Inquiries
info@lonza.com
-
Admin Team
admin@lonza.com
-
General Inquiries
contact@lonza.com
HQ: Temple City, California, United States
Fulgent Therapeutics
Fulgent Therapeutics, LLC is a pharmaceutical compShow more...any focusing on developing and commercializing innovative cancer therapeutics.
HQ: Temple City, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Nov 7, 2022
Founded Date: 2011
Company Type: For Profit
Stock Symbol: NASDAQ:FLGT
Operating Status: Active
17 Emails
1 Phones
Main email format: ssmith@fulgentgenetics.com (69.2%)
-
James Liu
Director of System Architecture,Enterprise Systems Architect
j**u@fulgentgenetics.com
-
Lawrence Weiss
l****s@fulgentgenetics.com
-
Ming Hsieh
m*******h@fulgentgenetics.com
-
Alex Witterschein
a**************n@fulgentgenetics.com
-
Erin Heaney
e*****y@fulgentgenetics.com
-
Eric Chen
e******n@fulgentgenetics.com
-
Rod Gervacio
CLS Lead
r*******o@fulgentgenetics.com
-
Spencer Young
Solutions/Software Analyst/Scientist/Engineer
s****g@fulgentgenetics.com
-
Benjamin Ramos
Talent Acquisition Specialist
b****s@fulgentgenetics.com
-
Doreen Ng
VP, Operations & Compliance | General Manager (Houston)
d******g@fulgentgenetics.com
-
Natalie Prescott
General Counsel & Chief Privacy Officer
n*******t@fulgentgenetics.com
-
Hanlin Gao
Lab Director and Chief Scientific Officer
h**o@fulgentgenetics.com
-
Paul Kim
Chief Financial Officer
p**m@fulgentgenetics.com
-
General Inquiries
info@fulgentgenetics.com
-
Customer Service
lacsupport@fulgentgenetics.com
-
Unclassified inbox
insurance@fulgentgenetics.com
-
General Inquiries
info@fulgent-therapeutics.com
HQ: Northbrook, Illinois, United States
Horizon Pharma
Horizon Therapeutics focuses on the development ofShow more... prescription drugs for mild to moderate pain relief and arthritis.
HQ: Northbrook, Illinois, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Delisted
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Dec 12, 2022
Founded Date: 2005
Company Type: For Profit
Stock Symbol: NASDAQ:HZNP
Operating Status: Active
14 Emails
1 Phones
Main email format: ssmith@horizontherapeutics.com (54.5%)
-
Shvetali Thatte
s*************e@horizontherapeutics.com.If
2**********0
-
Tina Ventura
t**********a@horizontherapeutics.com
-
Lou Scerbo
l*****o@horizontherapeutics.com
-
Maria Tello
m****o@horizontherapeutics.com
-
Randall Schenck
r*************k@horizontherapeutics.com
-
Paul Vanek
p********k@horizontherapeutics.com
-
Anne O'Donnell
a*******l@horizontherapeutics.com
-
Todd Smith
t****h@horizontherapeutics.com
-
James Inglis
j*****s@horizontherapeutics.com
-
John Croatt
Regional Account Director
j*********t@horizontherapeutics.com
-
Liz Gutierrez
l********z@horizontherapeutics.com
-
Susanna Frydryk
s******k@horizontherapeutics.com
-
Customer Service
customerservice@horizontherapeutics.com
-
Unclassified inbox
jwhalen@horizonpharma.com
HQ: Woonsocket, Rhode Island, United States
CVSPharmacy
CVSPharmacy is a retail pharmacy that offers prescShow more...ription drugs, over-the-counter drugs, beauty products, and cosmetics.
HQ: Woonsocket, Rhode Island, United States
Specialized In: Consumer Goods & FMCG, Healthcare & Medical, Pharmaceuticals, E-commerce & Retail
Business Type: Private
Employees: 10001+
Rounds: Debt Financing
Last Investment Activity: Mar 12, 2024
Founded Date: 1963
Company Type: For Profit
Operating Status: Active
11 Emails
0 Phones
Main email format: ssmith@cvs.com (81.8%)
-
Brittany Starcher
b*******r@cvs.com
-
Kelly Panuska
k******a@cvs.com
-
Edith M Pagan
e*****n@cvs.com
-
Dan Mccoy
d****y@cvs.com
-
Christine Molina
c*****a@cvs.com
-
Mai Vang
m***g@cvs.com
-
Doni Bobes
d****s@cvs.com
-
Sherri Potenzone
s********e@cvs.com
-
Omar Monarrez
o*******z@cvs.com
-
Carolyn Craft
c***t@cvs.com
-
Nagma Gargi
ngargi@cvs.com
-
General Inquiries
info@cvs.com
HQ: London, England, United Kingdom
Medicines and Healthcare products Regulatory Agency
An executive agency of the Department of Health, eShow more...xists to enhance and improve the health of millions of people every day.
HQ: London, England, United Kingdom
Specialized In: Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 1001-5000
Rounds: Grant
Last Investment Activity: Mar 29, 2023
Founded Date: Jan 1, 2003
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
Investor Type: Government Office
11 Emails
0 Phones
Main email format: sarah.smith@gov.uk (100.0%)
-
Sadiq Khan
s********n@london.gov.uk
-
Antony Phillipson
a***************n@fco.gov.uk
-
Gerwyn Evans
g**********s@wales.gsi.gov.uk
-
Max Caller
m********r@birmingham.gov.uk
-
Robin Porter
r**********r@luton.gov.uk
-
Jason Leitch
j**********h@scotland.gsi.gov.uk
-
Antonia Romeo
Permanent Secretary
a***********o@cabinetoffice.gov.uk
-
John Mills
j********s@fife.gov.uk
-
Antony Phillipson
a***************n@www.gov.uk
-
Antonia Romeo
Permanent Secretary
a***********o@justice.gsi.gov.uk
-
Archie Laing
archie.laing@gov.uk
-
General Inquiries
info@gov.uk
HQ: Durham, North Carolina, United States
KBI Biopharma
KBI Biopharma, Inc. (KBI) is a leading developmentShow more... and contract manufacturing organization serving the biopharmaceutical industry. We help
HQ: Durham, North Carolina, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Manufacturing & Industrial
Business Type: Private
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Apr 15, 2024
Founded Date: 1996
Number of Exits: 3
Company Type: For Profit
Operating Status: Active
13 Emails
0 Phones
Main email format: ssmith@kbibiopharma.com (100.0%)
-
Chad Cleveland
Director - Data Integrity | Global Quality & Compliance
c********d@kbibiopharma.com
-
Nicolas Fouque
Director of Manufacturing Science and Technologies - Geneva
n*****e@kbibiopharma.com
-
Allison Fallon
Talent Acquisition Specialist III
a*****n@kbibiopharma.com
-
Davinder Singh
Vice President Finance
d****h@kbibiopharma.com
-
Jeanie Lipscombe
Recruiting Specialist
j*****s@kbibiopharma.com
-
Robin Elleston
Director Of Quality Assurance
r*******n@kbibiopharma.com
-
Thomas Bellocci
Supply Chain Director
t*******i@kbibiopharma.com
-
Simon Bickley
Director Global Procurement
s******y@kbibiopharma.com
-
Chandra Kelley
Vice President, Business Development
c*****y@kbibiopharma.com
-
Chioma Otti
Microbiology Specialist
c***i@kbibiopharma.com
-
Marykay Marchigiani
Chief Financial Officer
m**********i@kbibiopharma.com
-
Unclassified inbox
swakefield@kbibiopharma.com
-
General Inquiries
contact@kbibiopharma.com
HQ: Tarrytown, New York, United States
Regeneron
Regeneron Pharmaceuticals specializes in the discoShow more...very, development, and commercialization of innovative medicines.
HQ: Tarrytown, New York, United States
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Sep 6, 2024
Venture Stage: Early Stage Venture
Founded Date: 1988
Number of Exits: obfuscatedobfuscated
Company Type: For Profit
Stock Symbol: NASDAQ:REGN
Operating Status: Active
11 Emails
0 Phones
Main email format: sarah.smith@regeneron.com (100.0%)
-
Boris Gorovits
b************s@regeneron.com
-
Jacky Space
j**************e@regeneron.com
-
Petra Rietschel
Senior Director Clinical Development ImmunoOncology
p*************l@regeneron.com
-
Catherine Armstrong Bccl
c************l@regeneron.com
-
Mena Soliman
m**********n@regeneron.com
-
Heather Hammond
h*************d@regeneron.com
-
Sarah Ghosh
s*********h@regeneron.com
-
Sofia Caruso
s**********o@regeneron.com
-
Jimmy Sanders
j***********s@regeneron.com
-
Lisa Flanagan
Director, Patent Attorney- Therapeutics IP
l***********n@regeneron.com
-
Madison Lee
madison.lee@regeneron.com
-
General Inquiries
info@regeneron.com
HQ: Palo Alto, California, United States
Jazz Pharmaceuticals
Jazz Pharmaceuticals is a specialty pharmaceuticalShow more... company that identifies, develops and commercializes innovative treatments.
HQ: Palo Alto, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Debt
Last Investment Activity: Feb 28, 2024
Founded Date: 2003
Company Type: For Profit
Stock Symbol: NASDAQ:JAZZ
Operating Status: Active
12 Emails
0 Phones
Main email format: sarah.smith@jazzpharma.com (100.0%)
-
Bruce Cozadd
Chief Executive Officer
b**********d@jazzpharma.com
-
Charlotte Nortvedt
c****************t@jazzpharma.com
-
Sam Hills
Global Workplace / Facilities Manager
s*******s@jazzpharma.com
-
Remy Sakkers
r**********s@jazzpharma.com
-
Lynette Thomas
l************s@jazzpharma.com
-
James Cekola
Corporate Counsel, Intellectual Property Litigation
j**********a@jazzpharma.com
-
Valmira Hoxhaj
v************j@jazzpharma.com
-
Todd Johnson
t**********n@jazzpharma.com
-
Robert Fell
r*********l@jazzpharma.com
-
Temire Bobegbe
t************e@jazzpharma.com
-
General Inquiries
investorinfo@jazzpharma.com
-
General Inquiries
contact@jazzpharma.com
HQ: Eagan, Minnesota, United States
Prime Therapeutics
Prime Therapeutics is an independent pharmacy beneShow more...fit manager that primarily serves Blue Cross Blue Shield plans
HQ: Eagan, Minnesota, United States
Specialized In: Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 5001-10000
Last Investment Activity: Jun 10, 2024
Founded Date: 1990
Company Type: For Profit
Operating Status: Active
11 Emails
1 Phones
Main email format: sarah.smith@primetherapeutics.com (77.8%)
-
Mostafa Kamal
Chief Executive Officer and President
m***********l@primetherapeutics.com
T***************************************************************************************************************m
-
Jing Kang
Specialty Clinical Program Director
j***g@primetherapeutics.com
-
Melissa Hogstad
Director Pharmacy Trade Relations
m******d@primetherapeutics.com
-
Shannon Brogden
Pharmacy Technician
s*************n@primetherapeutics.com
-
Caitlin Sandin
Sr. Clinical Review Technician
c************n@primetherapeutics.com
-
John Klimek
IT Budget and Resource Manager
j*********k@primetherapeutics.com
-
Amanda Leemhuis
Technician
a*************s@primetherapeutics.com
-
Laura Nadeau
Enterprise Portfolio Management Principal
l**********u@primetherapeutics.com
-
Chris Janssens
Senior Director, Trade Client Relations
c************s@primetherapeutics.com
-
Cameron M Kracke
c*****e@primetherapeutics.com
-
Unclassified inbox
RxNetworksDept@primetherapeutics.com
HQ: San Diego, California, United States
Sorrento Therapeutics
Sorrento Therapeutics is focused on the developmenShow more...t of proprietary drug therapeutics for addressing unmet medical needs.
HQ: San Diego, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 27, 2024
Founded Date: 2006
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:SRNE
Operating Status: Active
14 Emails
0 Phones
Main email format: ssmith@sorrentotherapeutics.com (100.0%)
-
Jaisim Shah
President & Chief Executive Officer
j***h@sorrentotherapeutics.com
-
Yan Li
Senior Scientist, Antibody Technology Development
y*i@sorrentotherapeutics.com
-
Dean Ferrigno
Vice President Of Finance
d*******o@sorrentotherapeutics.com
-
Vanessa Mendez
Quality
v*****z@sorrentotherapeutics.com
-
Ryan Tang
It Director
r***g@sorrentotherapeutics.com
-
Dindo Sy Chu
Vice President Finance
d**u@sorrentotherapeutics.com
-
Hua Huang
Director
h****g@sorrentotherapeutics.com
-
Mark Brunswick
SVP Head of Regulatory Affairs and Quality
m********k@sorrentotherapeutics.com
-
Silvia Chang
Head of Small Molecule Program Management/Executive Director Program Management
s****g@sorrentotherapeutics.com
-
Meredith Childers
Senior Writer
m*******s@sorrentotherapeutics.com
-
General Inquiries
info@sorrentotherapeutics.com
-
Admin Team
admin@sorrentotherapeutics.com
-
Management Department
manager@sorrentotherapeutics.com
-
Legal Department
legal@sorrentotherapeutics.com
HQ: Mumbai, Maharashtra, India
Cipla
Cipla is a drug manufacturing company that focusesShow more... on a variety of pharmaceutical products.
HQ: Mumbai, Maharashtra, India
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 10001+
Last Investment Activity: Jul 28, 2024
Founded Date: 1935
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NSE:CIPLA
Operating Status: Active
14 Emails
0 Phones
Main email format: sarah.smith@cipla.com (90.0%)
-
Yusuf Hamied
Chairman of the Board
y**********d@cipla.com
-
Narendra Choudhari
Director & Sr Marketing Head Cipla Ltd.
n****************i@cipla.com
-
Mangesh Vaze
Sr Director
m**********e@cipla.com
-
Priya Hargunani
Deputy Manager Medical Services (Oncology)
p*************i@cipla.com
-
Prathamesh Govekar
Director
p****************r@cipla.com
-
Lakshya Patil
Production Officer
l***********l@cipla.com
-
Devaughn Stephens
Head of Human Resources @ InvaGen Pharmaceuticals, Inc.
d***************s@cipla.com
-
Rathindra Das
Management Staff-Finance (Corporate Regulatory)
r***********s@cipla.com
-
Samina Vaziralli
Global Head - Strategy & New Ventures
s****a@cipla.com
-
Satyen Manikani
s*************i@cipla.com
-
General Inquiries
contactus@cipla.com
-
Unclassified inbox
Cipla.cs@cipla.com
-
General Inquiries
Contact@cipla.com
-
Unclassified inbox
drugsafety@cipla.com
HQ: Boston, Massachusetts, United States
Ginkgo Bioworks
Ginkgo Bioworks is a developer of biological enginShow more...eering products and custom microbes across multiple markets.
HQ: Boston, Massachusetts, United States
Specialized In: Pharmaceuticals, Biotechnology, Manufacturing & Industrial
Business Type: Public
Employees: 1001-5000
Rounds: Grant
Last Investment Activity: Mar 27, 2024
Founded Date: 2008
Number of Exits: 1
Company Type: For Profit
Stock Symbol: BMV:DNA
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah@ginkgobioworks.com (62.5%)
-
Christina Agapakis
Creative Director
c*******a@ginkgobioworks.com
-
Ken Situ
It Consultant
k******u@ginkgobioworks.com
-
Zachary King
Director Of Marketing Operations
z**********g@ginkgobioworks.com
-
Jhonny Martinez
Facilities Technician
j*************z@ginkgobioworks.com
-
Sean Leblanc
Senior Director of Foundry Operations
s**n@ginkgobioworks.com
-
Yaoyu Yang
Principal Software Engineer
y***u@ginkgobioworks.com
-
Tomek Brzezinski
Automation Engineer
t***k@ginkgobioworks.com
-
Soon Gang Choi
Senior Test Engineer
s**n@ginkgobioworks.com
-
Ian Meyer
Associate Director, Strategic Finance
i*n@ginkgobioworks.com
-
General Inquiries
info@ginkgobioworks.com
HQ: New York, New York, United States
Loxo Oncology
Loxo Oncology is a biopharmaceutical company focusShow more...ed on targeted cancer therapies for genetically-defined patient populations.
HQ: New York, New York, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Oct 17, 2022
Founded Date: 2013
Company Type: For Profit
Stock Symbol: NASDAQ:LOXO
Operating Status: Active
11 Emails
0 Phones
Main email format: ssmith@loxooncology.com (87.5%)
-
Lee S Scheible
Director, Early Phase Oncology, Loxo Oncology at Lilly
l*******e@loxooncology.com
-
Jinmi Heo
Director
j**o@loxooncology.com
-
Tamas Benkovics
Director
t********s@loxooncology.com
-
Alba Luengo
Principal Scientist
a*****o@loxooncology.com
-
Bojana Jovanovic
Senior Scientific Lead, Clinical Biomarker Development
b********c@loxooncology.com
-
Tracey Marrone
Talent Acquisition Manager
t******e@loxooncology.com
-
Nathan Wright
Research Fellow
n*****t@loxooncology.com
-
Ipsita Roy
Sr. Program/Project Manager
i**y@loxooncology.com
-
Nisha Nanda
Director, Clinical Science and Development
n***a@loxooncology.com
-
General Inquiries
info@loxooncology.com
-
Unclassified inbox
clinicaltrials@loxooncology.com
HQ: Madison, Wisconsin, United States
Allergan
Allergan is a global pharmaceutical company.
HQ: Madison, Wisconsin, United States
Specialized In: Biotechnology, Education & E-learning, Healthcare & Medical, Pharmaceuticals, Universities & Colleges
Acquired by: AbbVie
Business Type: Public
Employees: 10001+
Last Investment Activity: Aug 13, 2024
Founded Date: 1948
Company Type: For Profit
Stock Symbol: NYSE:AGN
Operating Status: Active
8 Emails
0 Phones
-
Natalie Anderten
Director, Clinical Development Operations
c************e@allergan.com
-
Lou Foytik
Associate Director, Contract Account Management
f********u@allergan.com
-
Vicky Yuan
Pr. Statistical SAS Programmer
y********y@allergan.com
-
Delaney Ahern
Brand Marketing, BOTOX® Cosmetic
a***********y@allergan.com
-
Viresh Thakerar
International External Innovation Lead
t*************h@allergan.com
-
Jamie Weidle
Senior Business Development Manager
w**********e@allergan.com
-
George Saltzberg
s**************e@allergan.com
-
Sharon DeFeo
defeo_sharon@allergan.com
-
General Inquiries
info@allergan.com
HQ: Charlotte, North Carolina, United States
Albemarle
Albemarle is a specialty chemical company focused Show more...on lithium, bromine, and refining catalysts.
HQ: Charlotte, North Carolina, United States
Specialized In: Manufacturing & Industrial, Construction Companies, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 14, 2024
Founded Date: 1994
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NYSE:ALB
Operating Status: Active
9 Emails
0 Phones
Main email format: sarah.smith@albemarle.com (100.0%)
-
Tatiana Lo
LAUNCH Rotational Program Associate Engineering
t********o@albemarle.com
-
Samantha Stutz
Process Engineer
s************z@albemarle.com
-
Tamaria Lynch
Vice President Finance
t***********h@albemarle.com
-
Jesse Counihan
North America Region Procurement Manager
j************n@albemarle.com
-
Eric Brooks
Key Account Manager
e*********s@albemarle.com
-
Patrick Thompson
Chief Information & Digital Transformation Officer
p**************n@albemarle.com
-
Chris Faria
c*********a@albemarle.com
-
Apurba Sakti
Data Science Advisor
a**********i@albemarle.com
-
Sales Department
albsales@albemarle.com
HQ: Bothell, Washington, United States
Seagen
Seagen is a clinical-stage biotechnology company dShow more...edicated to improving patient outcomes with advanced antibody-drug conjugate technology.
HQ: Bothell, Washington, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 12, 2024
Founded Date: 1998
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:SGEN
Operating Status: Active
9 Emails
0 Phones
Main email format: ssmith@seagen.com (83.3%)
-
Guy Padbury
Senior Vice President, Translational Sciences
g******y@seagen.com
-
Bryce Mansfield
Executive Director, R&D Quality
b********d@seagen.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k*****i@seagen.com
-
Davina Sparks Henderson
Sr Manager. Field Reimbursement
d********n@seagen.com
-
Virginie Oble Bouvet
v***e@seagen.com
-
Peter Senter
VP, Chemistry,VP, Distinguished Research Fellow
p***r@seagen.com
-
Marcel Koopman
International Product Manager Oncology
m******n@seagen.com
-
Jayeshkumar Soneji
j*****i@seagen.com
-
General Inquiries
contact@seagen.com
HQ: Albany, New York, United States
Albany Molecular Research
“Albany Molecular Research Inc. provides scientifiShow more...c services, products and technologies that improve quality of life while delivering
HQ: Albany, New York, United States
Specialized In: Biotechnology, Manufacturing & Industrial, Pharmaceuticals
Business Type: Delisted
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Jul 20, 2021
Founded Date: 1991
Company Type: For Profit
Stock Symbol: NASDAQ:AMRI
Operating Status: Active
11 Emails
0 Phones
Main email format: sarah.smith@amriglobal.com (100.0%)
-
Andrew Boze
Research Scientist I
a*********e@amriglobal.com
-
Steven Pawlows
Senior Manager
s************s@amriglobal.com
-
Susan Billings
Vice President & Global Head of Business Development
s************s@amriglobal.com
-
Griffin White
g***********e@amriglobal.com
-
Ikia Pwalther
Senior Director Business Development
i***********r@amriglobal.com
-
Tim Tuegel
t********l@amriglobal.com
-
Michael Haswell
m*************l@amriglobal.com
-
Shane Brown
s*********n@amriglobal.com
-
General Inquiries
InvestorInfo@amriglobal.com
-
Unclassified inbox
patty.eisenhaur@amriglobal.com
-
Unclassified inbox
seena.sankar@amriglobal.com
HQ: San Diego, California, United States
Mirati Therapeutics
Mirati Therapeutics is a Biotechnology company locShow more...ated in 9363 Towne Centre Dr, San Diego, CA, United States.
HQ: San Diego, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Jan 24, 2024
Founded Date: Dec 13, 1995
Company Type: For Profit
Stock Symbol: NASDAQ:MRTX
Operating Status: Active
8 Emails
0 Phones
Main email format: ssmith@mirati.com (60.0%)
-
James Christensen
Chief Scientific Officer
c**********j@mirati.com
-
Jing He
Associate Director Biostatistics
j*e@mirati.com
-
Maggie Ryan Laughlin
Human Resources Director, Human Resources Business Partner
l*******m@mirati.com
-
Roch Switlik
Head Of Supply Chain Management
r**h@mirati.com
-
Stephen K Lee
Associate Director
l**s@mirati.com
-
Augustine Bourne
a*****e@mirati.com
-
Lisa Trapp
Senior Director, Finance
l****p@mirati.com
-
General Inquiries
info@mirati.com
HQ: Hørsholm, Hovedstaden, Denmark
ALK Abelló
ALK is a global research-driven pharmaceutical comShow more...pany that focuses on prevention, diagnosis and treatment of allergies.
HQ: Hørsholm, Hovedstaden, Denmark
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Last Investment Activity: Aug 27, 2024
Founded Date: 1923
Number of Exits: 1
Company Type: For Profit
Stock Symbol: CPH:ALK
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah.smith@alk-abello.com (83.3%)
-
Louise Dahlgaard
Senior Global Pricing Manager
l**************d@alk-abello.com
-
Connie Kristiansen
c****************n@alk-abello.com
-
Martin Rud Pedersen
Acting Senior Vice President, Global Clinical Development
m*************n@alk-abello.com
-
Manuel Lombardero
Director CMC Development
m***************o@alk-abello.com
-
Kristina Benedict
k***************t@alk-abello.com
-
Josephine Licht
Chemist
j*************t@alk-abello.com
-
Suna Said
Founder and CEO
s******d@gmail.com
-
Unclassified inbox
reception@alk-abello.com
-
Customer Service
customer.service@alk-abello.com
-
Unclassified inbox
f.bayard@alk-abello.com
HQ: Castres-gironde, Aquitaine, France
Pierre Fabre
Pierre Fabre is a pharmaceutical manufacturing firShow more...m that supplies skincare, haircare, personal care, and dermo cosmetic products.
HQ: Castres-gironde, Aquitaine, France
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Business Type: Private
Employees: 10001+
Last Investment Activity: Jun 1, 2024
Founded Date: 1961
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
8 Emails
0 Phones
Main email format: sarah.smith@pierre-fabre.com (100.0%)
-
Dominique Gougeon
Business Unit Director Oncology France
d***************n@pierre-fabre.com
-
Eric Ducournau
President, CEO of dermo-cosmetics business, To 1,4 bn €
e************u@pierre-fabre.com
-
isabelle roumat
assistante de réseau
i*************t@pierre-fabre.com
-
Jacqueline Flam
Vice President Of Marketing
j*************m@pierre-fabre.com
-
Paul Croisoeuil
Responsable Marketing France - Eau Thermale Avène
p***************l@pierre-fabre.com
-
Celine Joubert
Déléguée pharmaceutique LYON
c************t@pierre-fabre.com
-
Delphine Andrieu
Chef de produits senior @KLORANE🌿🇫🇷 Marketing opérationnel | Capillaires
d**************u@pierre-fabre.com
-
Unclassified inbox
contact.pf@pierre-fabre.com
HQ: Saint-prex, Vaud, Switzerland
Ferring
Ferring is a biopharmaceutical company that develoShow more...ps reproductive medicine for healthacare sectors.
HQ: Saint-prex, Vaud, Switzerland
Specialized In: Biotechnology, Manufacturing & Industrial, Pharmaceuticals
Business Type: Private
Employees: 5001-10000
Rounds: Debt Financing
Last Investment Activity: Jan 16, 2024
Founded Date: 1950
Company Type: For Profit
Operating Status: Active
12 Emails
0 Phones
Main email format: sarah.smith@ferring.com (100.0%)
-
Casper Johansen
Director Business Development, Search & Evaluation
c*************n@ferring.com
-
Emilia Brusco
HR Director, South America
e***********o@ferring.com
-
Elda Dinaj
Global Strategic Brand Leader, Gastroenterology & Endocrinology
e********j@ferring.com
-
Camilla Munksgaard
Associate Director, HR
c****************d@ferring.com
-
Brent Ragans
President, Ferring Pharmaceuticals U.S.
b**********s@ferring.com
-
Phil Hanfling
Manager, Site Contracts
p***********g@ferring.com
-
Anie Azroyan, PhD, MBA
a**********n@ferring.com
-
General Inquiries
info@ferring.com
-
Admin Team
admin@ferring.com
-
Investor Relations
investor@ferring.com
-
General Inquiries
contact@ferring.com
-
Sales Department
sales@ferring.com
HQ: Columbus, Ohio, United States
Battelle
Battelle Memorial Institute is a nonprofit researcShow more...h and development organization.
HQ: Columbus, Ohio, United States
Specialized In: Pharmaceuticals
Business Type: Private
Employees: 10001+
Rounds: Grant
Last Investment Activity: Jan 17, 2024
Founded Date: 1923
Number of Exits: 1
Company Type: Non-profit
Operating Status: Active
8 Emails
1 Phones
Main email format: smiths@battelle.org (100.0%)
-
Cassandra Manos
Senior Contracts Manager
m*************a@bah.com
-
Joe Cochran
Aviation Security Division Manager
c******j@battelle.org
-
Tesema Chekol
Senior Research Scientist
c*****t@battelle.org
-
Alexa Konstantinos
k***********a@battelle.org
-
Anthony Mitchell
m*******a@battelle.org
-
Joseph Kola
Director, Strategy and Operational Efficiency
k***j@battelle.org
-
David White
Chief Information Officer
h*****l@battelle.org
-
Unclassified inbox
solutions@battelle.org
HQ: Pittsburgh, Pennsylvania, United States
Giant Eagle
Giant Eagle is a national supermarket chain with sShow more...ome of their own brands of products.
HQ: Pittsburgh, Pennsylvania, United States
Specialized In: Technology & Software, Food Delivery, Pharmaceuticals, E-commerce & Retail
Business Type: Private
Employees: 10001+
Last Investment Activity: Apr 12, 2024
Founded Date: 1931
Company Type: For Profit
Operating Status: Active
8 Emails
1 Phones
Main email format: sarah.smith@gianteagle.com (100.0%)
-
Bill Artman
President
b*********n@gianteagle.com
-
Vincent Donofrio
Front End Operations Manager, East Divison
v**************o@gianteagle.com.If
4********1
-
Grocery Manager
grocery
g******************0@gianteagle.com
-
Gary Hay
Chief Technology Officer
g******y@gianteagle.com
-
Susan Raderridgeway
Regional Facilities Manager
s*****************y@gianteagle.com
-
Chris Forde
Sr. Category Manager, Dairy
c*********e@gianteagle.com
-
Daniela Mayol
d***********l@gianteagle.com
-
Unclassified inbox
gianteaglerx@mscripts.com
HQ: Burlington, Massachusetts, United States
inVentiv Health
inVentiv Health offers clinical and commercial proShow more...fessional services to help biopharmaceutical companies streamline their processes.
HQ: Burlington, Massachusetts, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Rounds: Private Equity
Last Investment Activity: Jan 11, 2018
Founded Date: 1996
Number of Exits: 1
Company Type: For Profit
Operating Status: Closed
7 Emails
0 Phones
Main email format: sarah.smith@inventivhealth.com (100.0%)
-
Yuet Mei Han
IT Senior Analyst
y******n@inventivhealth.com
-
Jim Owers
Director, Digital Strategy and Head of Digital Production
j*******s@inventivhealth.com
-
Ann-Marie Terry
Clinical Research Associate II
a************y@inventivhealth.com
-
Latrell Rivers
l************s@inventivhealth.com
-
Vaibhav Divekar
Senior CDM
v*************r@inventivhealth.com
-
Martin Prosser
Senior Business Development Director
m************r@inventivhealth.com
-
Thomas Carlo Maria Topini
thomas.topini@inventivhealth.com
-
General Inquiries
info@inventivhealth.com
HQ: Cambridge, Massachusetts, United States
Genzyme
Genzyme Corporation (Genzyme) is a biotechnology cShow more...ompany. The Company's product and service portfolio is focused on rare genetic disease
HQ: Cambridge, Massachusetts, United States
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Private
Employees: 10001+
Last Investment Activity: Jul 30, 2024
Founded Date: 1981
Number of Exits: 3
Company Type: For Profit
Operating Status: Closed
7 Emails
0 Phones
Main email format: sarah.smith@genzyme.com (100.0%)
-
Helene Nagy
Label Development Manager, Clinical Supplies
h*********y@genzyme.com
-
Patti Nardi
Head of Global Product Supply Chain
p*********i@genzyme.com
-
Philippe Mazars
Quality Control Associate Director
p*************s@genzyme.com
-
Bryan Gillis
b**********s@genzyme.com
-
Eliana Clark
Chief Technical Officer
e**********k@genzyme.com
-
Morrill Reynolds
Principal Project Manager
m**************s@genzyme.com
-
Louise Harney
louise.harney@genzyme.com
-
General Inquiries
info@genzyme.com
HQ: Richmond, Virginia, United States
Indivior
Indivior is a specialty pharmaceuticals business.
HQ: Richmond, Virginia, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Aug 21, 2024
Founded Date: 2014
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:INDV
Operating Status: Active
8 Emails
0 Phones
Main email format: sarah.smith@indivior.com (100.0%)
-
Cathy Thomas
National Sales Manager
c**********s@indivior.com
-
Jennie Witherspoon
Sr. Clinical Specialist
j****************n@indivior.com
-
Diana Minervini
Channel/Trade Accounts
d*************i@indivior.com
-
Sincear Fountain
Regional Account Director
s**************n@indivior.com
-
Naomi Guinness
UK & Ireland Talent Acquisition Specialist (VIA Korn Ferry RPO)
n************s@indivior.com
-
Steve Johnson
Senior Area Sales Manager - Behavioral Health
s***********n@indivior.com
-
Rob Vinson
Specialty Sales Consultant|Injectables Buy and Bill|Product Launches
r********n@indivior.com
-
Unclassified inbox
Tom.Corran@indivior.com
HQ: Castres-gironde, Aquitaine, France
Pierre Fabre
Pierre Fabre is a pharmaceutical manufacturing firShow more...m that supplies skincare, haircare, personal care, and dermo cosmetic products.
HQ: Castres-gironde, Aquitaine, France
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Business Type: Private
Employees: 10001+
Last Investment Activity: Jun 1, 2024
Founded Date: 1961
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
8 Emails
0 Phones
Main email format: sarah.smith@pierre-fabre.com (100.0%)
-
Dominique Gougeon
Business Unit Director Oncology France
d***************n@pierre-fabre.com
-
Eric Ducournau
President, CEO of dermo-cosmetics business, To 1,4 bn €
e************u@pierre-fabre.com
-
isabelle roumat
assistante de réseau
i*************t@pierre-fabre.com
-
Jacqueline Flam
Vice President Of Marketing
j*************m@pierre-fabre.com
-
Paul Croisoeuil
Responsable Marketing France - Eau Thermale Avène
p***************l@pierre-fabre.com
-
Celine Joubert
Déléguée pharmaceutique LYON
c************t@pierre-fabre.com
-
Delphine Andrieu
Chef de produits senior @KLORANE🌿🇫🇷 Marketing opérationnel | Capillaires
d**************u@pierre-fabre.com
-
Unclassified inbox
contact.pf@pierre-fabre.com
HQ: Hørsholm, Hovedstaden, Denmark
ALK Abelló
ALK is a global research-driven pharmaceutical comShow more...pany that focuses on prevention, diagnosis and treatment of allergies.
HQ: Hørsholm, Hovedstaden, Denmark
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Last Investment Activity: Mar 4, 2024
Founded Date: 1923
Number of Exits: 1
Company Type: For Profit
Stock Symbol: CPH:ALK
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah.smith@alk-abello.com (83.3%)
-
Louise Dahlgaard
Senior Global Pricing Manager
l**************d@alk-abello.com
-
Connie Kristiansen
c****************n@alk-abello.com
-
Martin Rud Pedersen
Acting Senior Vice President, Global Clinical Development
m*************n@alk-abello.com
-
Manuel Lombardero
Director CMC Development
m***************o@alk-abello.com
-
Kristina Benedict
k***************t@alk-abello.com
-
Josephine Licht
Chemist
j*************t@alk-abello.com
-
Suna Said
Founder and CEO
s******d@gmail.com
-
Unclassified inbox
reception@alk-abello.com
-
Customer Service
customer.service@alk-abello.com
-
Unclassified inbox
f.bayard@alk-abello.com
HQ: Göttingen, Niedersachsen, Germany
Sartorius
Sartorius helps its customers to develop and manufShow more...acture biotech medicines reliably, quickly, and economically.
HQ: Göttingen, Niedersachsen, Germany
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 5001-10000
Rounds: Post-IPO Debt
Last Investment Activity: Mar 18, 2024
Founded Date: 1870
Company Type: For Profit
Stock Symbol: ETR:SRT3
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah.smith@sartorius.com (100.0%)
-
Joachim Kreuzburg
Chairman of the Executive Board and CEO
j***************g@sartorius.com
-
Mareva Gueneron
Head Of Project Management Office (PMO)
m*************n@sartorius.com
-
Floris Smet
Manager - Process Development Consultants
f***********t@sartorius.com
-
Jeannine Hillmer
Field Account Manager
j**************r@sartorius.com
-
Sven Wagner
Head of Business Development
s*********r@sartorius.com
-
Vincent Galione
Digital Account Manager - Southeast
v*************e@sartorius.com
-
Dominik Kopp
Manager IT Service Framework
d**********p@sartorius.com
-
General Inquiries
info@sartorius.com
-
Admin Team
admin@sartorius.com
-
General Inquiries
info@sartorius-stedim.com
HQ: Cambridge, Cambridgeshire, United Kingdom
Horizon Discovery
Horizon is a gene editing company that designs & eShow more...ngineers genetically-modified cells, applying them to advance human health.
HQ: Cambridge, Cambridgeshire, United Kingdom
Specialized In: Pharmaceuticals, Biotechnology, Health Diagnostics
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 10, 2022
Founded Date: Jun 2007
Company Type: For Profit
Stock Symbol: LSE:HZD
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah.smith@horizondiscovery.com (100.0%)
-
Kevin Koker
Customer Service Manager
k*********r@horizondiscovery.com
-
Jon Aviles
General Manager
j********s@horizondiscovery.com
-
Natalie Cowan
Business Development Manager
n***********n@horizondiscovery.com
-
Jon Nunez
Vice President , Finance
j*******z@horizondiscovery.com
-
Jeffrey Dale
Business Development Manager, Midwest (South), Products and Services (including In Vivo)
j**********e@horizondiscovery.com
-
Abhay Joshi
Business Development Manager
a*********i@horizondiscovery.com
-
Hadas Raveh-Amit
Senior Scientist
h*************t@horizondiscovery.com
-
General Inquiries
info@horizondiscovery.com
-
Sales Department
sales@horizondiscovery.com
-
Legal Department
legal@horizondiscovery.com
HQ: Cambridge, Massachusetts, United States
Cullinan Oncology
Cullinan Oncology is a developer of an externally Show more...sourced cancer therapeutics used to end a drug program quickly.
HQ: Cambridge, Massachusetts, United States
Specialized In: Pharmaceuticals, Biotechnology, Medical Devices, Hospitals & Clinics
Business Type: Public
Employees: 11-50
Rounds: Post-IPO Equity
Last Investment Activity: Mar 14, 2024
Founded Date: 2017
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:CGEM
Operating Status: Active
7 Emails
0 Phones
Main email format: ssmith@cullinanoncology.com (100.0%)
-
Corinne Savill
Chief Business Officer
c*****l@cullinanoncology.com
-
Nadim Ahmed
President and CEO
n****d@cullinanoncology.com
-
Jennifer Michaelson
Chief Development Officer
j*********n@cullinanoncology.com
-
Leslie Mariani
Vice President, Finance and Operations
l******i@cullinanoncology.com
-
Jeffrey Trigilio
Chief Financial Officer
j*******o@cullinanoncology.com
-
Sal Firicano
VP and Head of Information Technology
s*******o@cullinanoncology.com
-
General Inquiries
info@cullinoncology.com
HQ: Shanghai, Shanghai, China
Fosun Pharma
Fosun Pharma is a pharmaceutical company.
HQ: Shanghai, Shanghai, China
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Debt Financing
Last Investment Activity: Mar 14, 2024
Founded Date: 1994
Number of Exits: 11
Company Type: For Profit
Stock Symbol: HKG:2196
Operating Status: Active
Investor Type: Venture Capital
12 Emails
0 Phones
Main email format: smiths@fosunpharma.com (83.3%)
-
Qiyu Chen
Executive Director , Chairman of the Board
c***q@fosunpharma.com
-
Aimin Hui
Executive Presendent of Fosun Pharma; President of Global R&D, Chief Medical Officer
h**a@fosunpharma.com
-
Lijun Wu
CSO of Fosun Pharma / Founder and Head of FUSION Bioventure
w*l@fosunpharma.com
-
Alex Zhu
Executive Director
z**a@fosunpharma.com
-
Zhu Xi
z*u@fosunpharma.com
-
Mike Xu
Co-President
x*m@fosunpharma.com
-
Investor Relations
ir@fosunpharma.com
-
Unclassified inbox
info.usa@fosunpharma.com
-
Unclassified inbox
fosunpharma@wsfg.hk
-
Unclassified inbox
int@fosunpharma.com
-
Unclassified inbox
LastF@fosunpharma.com
-
Unclassified inbox
lianzhengdc@fosunpharma.com
HQ: Gurgaon, Haryana, India
1mg
1mg is an online pharmacy network platform and genShow more...eric medicine engine.
HQ: Gurgaon, Haryana, India
Specialized In: E-commerce & Retail, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 51-100
Rounds: Venture - Series Unknown
Last Investment Activity: Nov 8, 2022
Founded Date: Feb 3, 2015
Company Type: For Profit
Operating Status: Active
12 Emails
1 Phones
Main email format: sarah@1mg.com (33.3%)
-
Prashant Tandon
CEO & Co-Founder
p******t@1mg.com
-
Gaurav Agarwal
Co-Founder & CTO
g*****a@1mg.com
*********4
-
Ravish Aanand
r***********d@1mg.com
-
Mike McGarr
Senior Engineering Leader, Desktop Foundations at Slack
mm@1mg.com
-
Tanmay Saksena
Chief Operating Officer
t****y@1mg.com
-
Arpit Sarin
Head- Marketplace Operations,Head of Business Insights- Retail
a*********n@1mg.com
-
General Inquiries
info@1mg.com
-
General Inquiries
hello@1mg.com
-
Customer Service
support@1mg.com
-
Sales Department
sales@1mg.com
-
Legal Department
legal@1mg.com
-
Unclassified inbox
care@1mg.com
HQ: Novato, California, United States
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the developmeShow more...nt of various products for the treatment of rare and ultra-rare diseases.
HQ: Novato, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Feb 26, 2024
Founded Date: 2010
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:RARE
Operating Status: Active
9 Emails
0 Phones
Main email format: ssmith@ultragenyx.com (83.3%)
-
John Klock
Founder
j**n@ultragenyx.com
-
Jung Cho
Associate Director of Validation
j**o@ultragenyx.com
-
Akhilesh Bhambhani
Sr. Director, Biologics Drug Product Development- Tech Dev/Tech Ops
a********i@ultragenyx.com
-
Marisa Capponi
Associate Director
m******i@ultragenyx.com
-
Benjamin Ehrhart
Vice President, Assistant General Counsel
b******t@ultragenyx.com
-
Xiaohui Lu
Senior Research Scientist
x*u@ultragenyx.com
-
General Inquiries
info@ultragenyx.com
-
Unclassified inbox
trialrecruitment@ultragenyx.com
-
Unclassified inbox
MCorley@ultragenyx.com
HQ: Stamford, Connecticut, United States
Purdue Pharma
Purdue Pharma develops, manufactures, and markets Show more...medications and consumer health products.
HQ: Stamford, Connecticut, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 5001-10000
Rounds: Grant
Last Investment Activity: Dec 4, 2023
Founded Date: 1892
Number of Exits: 2
Company Type: For Profit
Operating Status: Active
7 Emails
0 Phones
Main email format: sarah.smith@purduepharma.com (50.0%)
-
Cherilyn Calia
Business Analyst
c************a@purduepharma.com
-
Bill Watson
w****n@purduepharma.com
-
Heather Jordan
Industry Account Executive at SAP
j****n@purduepharma.com
-
Stephen Rayda
Global Head of Infrastructure and Client Services at Purdue Pharma L.P.
s***********a@purduepharma.com
-
Donna Krizik
Experienced Marketing Director | SEO | B2B Marketer | Content Strategist
dk@purduepharma.com
-
Marc Kesselman
S.V.P. & General Counsel
m************n@purduepharma.com
-
General Inquiries
purduemedInfo@pharma.com
HQ: Cincinnati, Ohio, United States
Medpace
Medpace, Inc., a clinical research organization, pShow more...rovides clinical development services for pharmaceutical and biotechnology
HQ: Cincinnati, Ohio, United States
Specialized In: Biotechnology, Pharmaceuticals
Acquired by: Cinven
Business Type: Public
Employees: 1001-5000
Last Investment Activity: Aug 12, 2024
Founded Date: 1992
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:MEDP
Operating Status: Active
6 Emails
1 Phones
Main email format: s.smith@medpace.com (100.0%)
-
Guido Moesker
Sr. Director Clinical Trial Management
g*******r@medpace.com
-
Angela White
Clinical Trial Manager
a*****e@medpace.com.If
2********2
-
Estelle Stephan
e*******n@medpace.com
-
Kelsey Neal
Quality Assurance Auditor
k****l@medpace.com
-
Serena Acquati
s*******i@medpace.com
-
General Inquiries
info@medpace.com
HQ: Dublin, Dublin, Ireland
Alkermes
Alkermes is a biotechnology company that develops,Show more... manufactures and commercializes medicines for the treatment of chronic diseases.
HQ: Dublin, Dublin, Ireland
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Aug 22, 2024
Founded Date: 1987
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:ALKS
Operating Status: Active
6 Emails
0 Phones
Main email format: sarah.smith@alkermes.com (100.0%)
-
Anne Tremmel
Hospital Business Manager
a**********l@alkermes.com
-
Patricia Hedrick
Senior Production Planner
p**************k@alkermes.com
-
Robin Kleiman
Vice President, CNS Biology
r***********n@alkermes.com
-
Leah Goodnight
Director, Thought Leader Engagement
l************t@alkermes.com
-
Patrick Laclair
Director, Commercial Contract Operations
p*************r@alkermes.com
-
Unclassified inbox
busdev@alkermes.com
HQ: Morrisville, North Carolina, United States
Syneos Health
Syneos Health, the only fully integrated end-to-enShow more...d clinical and commercial solution organization.
HQ: Morrisville, North Carolina, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Secondary
Last Investment Activity: Jan 12, 2024
Founded Date: 1985
Company Type: For Profit
Stock Symbol: NASDAQ:SYNH
Operating Status: Active
8 Emails
0 Phones
Main email format: sarah.smith@syneoshealth.com (100.0%)
-
Ian Dorrian
President Communications Europe
i*********n@syneoshealth.com
-
Sean Wallace
Clinical Technician
s**********e@syneoshealth.com
-
Elgin C Duckery
District Sales Manager
e***********y@syneoshealth.com
-
Aparna Sree
Talent Acquisition Spec II
a******p@syneoshealth.com
-
Agnieszka Mazek
International Corporate Recruiter II
a*************k@syneoshealth.com
-
Career Opportunities
jobs@syneoshealth.com
-
Unclassified inbox
abcdefghij@syneoshealth.com
-
Unclassified inbox
toby.marshall@syneoshealth.com
HQ: South San Francisco, California, United States
Theravance Biopharma
Theravance Biopharma is a biopharmaceutical companShow more...y with one approved product.
HQ: South San Francisco, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Jan 16, 2024
Founded Date: 1996
Company Type: For Profit
Stock Symbol: NASDAQ:TBPH
Operating Status: Active
8 Emails
0 Phones
Main email format: ssmith@theravance.com (100.0%)
-
Christopher Porter
Vice President, Development Strategy and Innovation
c*****r@theravance.com
-
Kerry Zampa
Head, Global Learning & Organization Development
k****a@theravance.com
-
Venkat Vutukuri
BI Analytics Lead Architect
v*******i@theravance.com
-
Punam Shaida
p*****a@theravance.com
-
Jesse Fecker
Senior Director, Chief US Patent Counsel
j*****r@theravance.com
-
General Inquiries
medinfo@theravance.com
-
General Press Inquiries
cypress@theravance.com
-
Investor Relations
investor.relations@theravance.com
HQ: New York, New York, United States
Owkin
Owkin is an AI precision medicine company with a vShow more...ision to find the right drug for every patient.
HQ: New York, New York, United States
Specialized In: AI & Machine Learning, Pharmaceuticals, Healthcare SaaS, SaaS
Business Type: Private
Employees: 251-500
Rounds: Series B
Last Investment Activity: Mar 26, 2024
Founded Date: 2016
Company Type: For Profit
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah.smith@owkin.com (50.0%)
-
Thomas Clozel
Co-Founder & CEO
tc@owkin.com
-
Thomas Clozel
Co-Founder & CEO
t***********l@owkin.com
-
Gilles Wainrib
Founder
gw@owkin.com
-
Darius Meadon
Chief Marketing Officer
d***********n@owkin.com
-
Antonia Twiston-Davies
a************r@owkin.com
-
General Inquiries
hello@owkin.com
-
Customer Service
support@owkin.com
-
General Inquiries
contact@owkin.com
-
Sales Department
sales@owkin.com
-
Legal Department
legal@owkin.com
HQ: Exton, Pennsylvania, United States
West Pharmaceutical Services
West Pharmaceutical Services is a manufacturer of Show more...technologically advanced containment and delivery systems for injectable medicines.
HQ: Exton, Pennsylvania, United States
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 5001-10000
Last Investment Activity: Jun 21, 2024
Founded Date: 1923
Company Type: For Profit
Stock Symbol: NYSE:WST
Operating Status: Active
9 Emails
1 Phones
Main email format: sarah.smith@westpharma.com (100.0%)
-
Rick Phelan
Information Technology, Sr. Director
r*********n@westpharma.com
-
Theodore Weir
Med Device & Pharma Program Manager
t***********r@westpharma.com
-
Séamus Kilbane
s************e@westpharma.com
-
Atul Patel
Vice President, Devices & Delivery Systems
a********l@westpharma.com
-
Preety Lall
p*********l@westpharma.com
-
Unclassified inbox
John.Sweeney@westpharma.com
-
Unclassified inbox
lynn.lundy@westpharma.com
-
Unclassified inbox
Kimberly.MacKay@westpharma.com
-
Customer Service
westpharmaceuticalservices@westpharma.com
HQ: South San Francisco, California, United States
Cytokinetics
Cytokinetics is a biopharmaceutical company develoShow more...ping therapies for debilitating diseases.
HQ: South San Francisco, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Debt
Last Investment Activity: Mar 15, 2024
Founded Date: 1998
Company Type: For Profit
Stock Symbol: NASDAQ:CYTK
Operating Status: Active
9 Emails
0 Phones
Main email format: ssmith@cytokinetics.com (100.0%)
-
Robert Blum
President & CEO
r***m@cytokinetics.com
-
Kymberly Hernandez
HR Director, Commercial and Medical Affairs
k********z@cytokinetics.com
-
Dean Reid
d***d@cytokinetics.com
-
Regina Sohn
Medical Director
r***n@cytokinetics.com
-
Tina Controy
t******y@cytokinetics.com
-
General Inquiries
info@cytokinetics.com
-
Investor Relations
investor@cytokinetics.com
-
Legal Department
legal@cytokinetics.com
-
Unclassified inbox
medicalaffairs@cytokinetics.com
HQ: Mumbai, Maharashtra, India
Piramal Enterprises
Piramal Group is a diversified conglomerate with oShow more...perational presence in pharma, financial services, information management and real estate.
HQ: Mumbai, Maharashtra, India
Specialized In: Finance & Banking, Technology & Software, Pharmaceuticals, Real Estate Agencies & Brokers
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 13, 2024
Founded Date: Dec 2, 1992
Company Type: For Profit
Stock Symbol: NSE:PEL
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah.smith@piramal.com (100.0%)
-
Nandini Piramal
Executive Director
n*************l@piramal.com
-
Swati Piramal
Vice Chairperson
s***********l@piramal.com
-
Ajay Piramal
Chairman
a**********l@piramal.com
-
Harinder Sikka
Group Director
h************a@piramal.com
-
Unmesh
Vice President Human Resources
u********i@piramal.com
-
Unclassified inbox
customercare@piramal.com
-
Unclassified inbox
nodal.officer@piramal.com
-
Unclassified inbox
medical.information@piramal.com
-
Unclassified inbox
contact.us@piramal.com
-
Unclassified inbox
corporate.communication@piramal.com
HQ: Woodcliff Lake, New Jersey, United States
Eagle Pharmaceuticals
Eagle Pharmaceuticals is a company focused on deveShow more...loping and commercializing injectable products in the critical care and oncology areas.
HQ: Woodcliff Lake, New Jersey, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics, Pharmaceuticals
Business Type: Public
Employees: 101-250
Rounds: Venture - Series Unknown
Last Investment Activity: May 22, 2024
Founded Date: 2007
Company Type: For Profit
Stock Symbol: NASDAQ:EGRX
Operating Status: Active
9 Emails
0 Phones
Main email format: ssmith@eagleus.com (100.0%)
-
Jorma Lalla
Vice President
j****a@eagleus.com
-
Brendan Killeen
Regional Sales Director
b******n@eagleus.com
-
David S Bricker
Vice President, Head Global Manufacturing and Supply
d******r@eagleus.com
-
Alan Eagle
a****e@eagleus.com
-
Daniel Maher
d****r@eagleus.com
-
General Inquiries
info@eagleus.com
-
Unclassified inbox
aelgohail@eagleus.com
-
Unclassified inbox
jlarocca@eagleus.com
-
Unclassified inbox
egrx@openboard.info
HQ: Paris, Ile-de-France, France
InVivo
InVivo helps agriculture cooperation regain their Show more...rightful place in the global food value chain.
HQ: Paris, Ile-de-France, France
Specialized In: AgTech, Pharmaceuticals, Healthcare & Medical
Business Type: Private
Employees: 5001-10000
Rounds: Private Equity
Last Investment Activity: Mar 5, 2024
Founded Date: 1945
Company Type: For Profit
Operating Status: Active
10 Emails
0 Phones
Main email format: ssmith@invivo-group.com (100.0%)
-
Maha Fournier
Group Chief Financial and Operating Officer
m*******r@invivo-group.com
-
Nathalie BAROTTE
Gestionnaire de carrières & RRH International
n******e@invivo-group.com
-
Edouard Lanckriet
e********t@invivo-group.com
-
Romain Affanni
r******i@invivo-group.com
-
Delphine CAMUS
d****s@invivo-group.com
-
General Inquiries
info@invivo-group.com
-
Admin Team
admin@invivo-group.com
-
Customer Service
support@invivo-group.com
-
General Inquiries
contact@invivo-group.com
-
Sales Department
sales@invivo-group.com
HQ: Palo Alto, California, United States
BridgeBio
BridgeBio focuses on the development and commerciaShow more...lization of precision medicines for various genetic diseases and cancers.
HQ: Palo Alto, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Mar 18, 2024
Founded Date: 2015
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:BBIO
Operating Status: Active
10 Emails
1 Phones
Main email format: ssmith@bridgebio.com (80.0%)
-
Neil Kumar
Co-Founder & CEO
n********r@bridgebio.com
-
Neil Kumar
Co-Founder & CEO
n****r@bridgebio.com
T*********************************************************************************m
-
Thomas Parker
Scientist II - MSAT Lead
t*****r@bridgebio.com
-
Jennifer Hodge
j****e@bridgebio.com
-
Brian Stephenson
b*********n@bridgebio.com
-
General Inquiries
info@bridgebio.com
-
Customer Service
support@bridgebio.com
-
Management Department
manager@bridgebio.com
-
General Inquiries
contact@bridgebio.com
-
Sales Department
sales@bridgebio.com
HQ: Suresnes, Ile-de-France, France
Servier
Servier is an pharmaceutical company governed by aShow more... non-profit foundation.
HQ: Suresnes, Ile-de-France, France
Specialized In: Healthcare & Medical, Medical Devices, Pharmaceuticals
Acquired by: AIvarix
Business Type: Private
Employees: 10001+
Last Investment Activity: Aug 7, 2024
Founded Date: 1954
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
6 Emails
0 Phones
Main email format: sarah.smith@servier.com (100.0%)
-
Victoria Vandzhura
International Project Director
v****************a@servier.com
-
François Tharaux
Alliance Director Business Development & Licensing
f**************x@servier.com
-
Sanket Salvi
Sr. Human Resources Business Partner
s**********i@servier.com
-
Walid Kamoun
Vice President, Global Head of R&D Oncology
w**********n@servier.com
-
Thomas Reynaud
Data Tech Lead
t************d@servier.com
-
General Press Inquiries
presse@servier.com
HQ: Smiths Falls, Ontario, Canada
Canopy Growth
Canopy Growth is a cannabis consumer product compaShow more...ny that manufactures medical cannabis to improve lives.
HQ: Smiths Falls, Ontario, Canada
Specialized In: Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 27, 2024
Founded Date: 2014
Number of Exits: 3
Company Type: For Profit
Stock Symbol: TSX:WEED
Operating Status: Active
6 Emails
0 Phones
Main email format: sarah.smith@canopygrowth.com (100.0%)
-
Bruce Linton
Founder
b**********n@canopygrowth.com
-
Rachit Gupta
Cloud Engineer - DBA Specialist
r**********a@canopygrowth.com
-
Ross Fenwick
Manager, Talent Acquisition
r**********k@canopygrowth.com
-
Scott W Huddle
s**********e@canopygrowth.com
-
Christelle Gedeon
Partner
c***************n@canopygrowth.com
-
Unclassified inbox
invest@canopygrowth.com
HQ: Wilmington, Delaware, United States
Incyte
Incyte is a drug discovery and development companyShow more... which hopes to build a proprietary product pipeline of novel small molecule drugs.
HQ: Wilmington, Delaware, United States
Specialized In: Biotechnology, Healthcare & Medical, Medical Devices, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Last Investment Activity: Aug 16, 2024
Founded Date: 1991
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NASDAQ:INCY
Operating Status: Active
5 Emails
0 Phones
Main email format: ssmith@incyte.com (100.0%)
-
John Janik
Vice President Clinical Research
j****k@incyte.com
-
Abdelhak AMARA KORBA
a****a@incyte.com
-
Allison Kozeny
a*****y@incyte.com
-
Nicola Stephens
Sales Representative
n*******s@incyte.com
-
General Inquiries
medinfo@incyte.com
HQ: Fort Myers, Florida, United States
NeoGenomics
NeoGenomics is a cancer reference laboratory that Show more...provides cancer testing and partnership programs to pathologists and oncologists.
HQ: Fort Myers, Florida, United States
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 18, 2024
Founded Date: Oct 29, 1998
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:NEO
Operating Status: Active
7 Emails
0 Phones
Main email format: ssmith@neogenomics.com (100.0%)
-
Ryan J Angell
Vice President, Oncology Services and Laboratory Collaborations
r*****l@neogenomics.com
-
David S Brooks
Divisional Vice President, Informatics
d*****s@neogenomics.com
-
Ricky Kleinsmith
Associate Director of Quality Management Systems
r*********h@neogenomics.com
-
Lakshmi Chandramohan
Principal Scientist, Associate Director, Molecular Assay Services
l***********n@neogenomics.com
-
Unclassified inbox
aimee.bui@neogenomics.com
-
Human Resources Team
HR@neogenomics.com
-
Human Resources Team
hr@neogenomics.com
HQ: Hamburg, Hamburg, Germany
Evotec
Evotec is a pharmaceutical and life science companShow more...y that provides drug discovery and gene therapy solutions.
HQ: Hamburg, Hamburg, Germany
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 5001-10000
Rounds: Grant
Last Investment Activity: Mar 28, 2024
Founded Date: 1993
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NASDAQ:EVO
Operating Status: Active
5 Emails
0 Phones
Main email format: sarah.smith@evotec.com (75.0%)
-
Benedict Chen
Vice President
b***********n@evotec.com
-
Alessandro Orsetti
a****************i@evotec.com
-
Alex Jakober
Sr Systems Engineer
a**********r@evotec.com
-
Christopher W.
IT Group Leader Site Services
c***********w@evotec.com
-
General Inquiries
info@evotec.com
HQ: Osaka-shi, Osaka, Japan
Shionogi
Shionogi is a pharmaceutical company that offers pShow more...harmaceuticals, diagnostic reagents, and medical devices.
HQ: Osaka-shi, Osaka, Japan
Specialized In: Biotechnology, Medical Devices, Pharmaceuticals
Business Type: Public
Employees: 5001-10000
Rounds: Grant
Last Investment Activity: Feb 27, 2024
Founded Date: Mar 17, 1878
Number of Exits: 3
Company Type: For Profit
Stock Symbol: TYO:4507
Operating Status: Active
7 Emails
0 Phones
Main email format: ssmith@shionogi.com (100.0%)
-
Donald Pirkl
Supplier Manager
d****l@shionogi.com
-
Calvin Smith
Key Account Manager
c****h@shionogi.com
-
Fabio De Gregorio
f*********o@shionogi.com
-
Sol Yates
s****s@shionogi.com
-
Unclassified inbox
ShionogiCommunications@shionogi.com
-
General Inquiries
contact@shionogi.eu
-
General Inquiries
info@shionogi.co.jp
HQ: San Diego, California, United States
Ligand Pharmaceuticals
Ligand is a biopharmaceutical company focused on dShow more...eveloping or acquiring technologies that help pharmaceutical companies.
HQ: San Diego, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 51-100
Rounds: Post-IPO Debt
Last Investment Activity: Mar 27, 2024
Founded Date: Sep 1, 1987
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:LGND
Operating Status: Active
8 Emails
0 Phones
Main email format: ssmith@ligand.com (66.7%)
-
John L. Higgins
CEO
j******s@ligand.com
-
Ram Kapil
Senior Director, Clinical Pharmacology
r****l@ligand.com
-
Jessica Wolzen
Associate Director, Regulatory & Operations
j******w@ligand.com
-
Paul Hadden
Managing Director
p*****n@ligand.com
-
General Inquiries
info@ligand.com
-
Admin Team
admin@ligand.com
-
General Inquiries
contact@ligand.com
-
Career Opportunities
jobs@ligand.com
HQ: Carlsbad, California, United States
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotShow more...echnology company developing novel cellular therapies to treat unmet medical needs.
HQ: Carlsbad, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Coaching & Consulting, Healthcare & Medical
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 6, 2024
Founded Date: Jan 1, 1990
Number of Exits: 1
Company Type: For Profit
Stock Symbol: TLV:BTX
Operating Status: Active
7 Emails
0 Phones
Main email format: ssmith@lineagecell.com (100.0%)
-
Jill Howe
Chief Financial Officer
j***e@lineagecell.com
-
Brian Culley
Chief Executive Officer at BioTime, Inc. (NYSE:BTX)
b*****y@lineagecell.com
-
Dan Giles
Business Development Manager
d****s@lineagecell.com
-
Aleksandra Jovanovic Poole
Vice President, Product Development
a****e@lineagecell.com
-
General Inquiries
info@lineagecell.com
-
General Inquiries
contact@lineagecell.com
-
Legal Department
legal@lineagecell.com
HQ: Suzhou, Jiangsu, China
Ascentage Pharma
Ascentage is a clinical-stage biopharmaceutical coShow more...mpany that develops drugs for the treatment of cancer.
HQ: Suzhou, Jiangsu, China
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Private
Employees: 101-250
Rounds: Series C
Last Investment Activity: Jan 2, 2024
Founded Date: 2009
Company Type: For Profit
Operating Status: Active
7 Emails
0 Phones
Main email format: ssmith@ascentagepharma.com (66.7%)
-
Muyun Yang
Investor Relations Manager
s***g@ascentagepharma.com
-
George Wong
Vice President of Product Development and Production
g***g@ascentagepharma.com
-
Geetha Bhat
Clinical Study manager, Clinical Operations
g*********t@ascentagepharma.com
-
Sherry Sun
Senior Medical Director
s**n@ascentagepharma.com
-
Unclassified inbox
PR@ascentagepharma.com
-
Unclassified inbox
bd@ascentagepharma.com
-
Unclassified inbox
cyang@ascentagepharma.com
HQ: Palo Alto, California, United States
Scilex Holding Company
Scilex Pharmaceuticals is an emerging pharmaceuticShow more...al company focused on acquiring and commercializing late-stage prescription products.
HQ: Palo Alto, California, United States
Specialized In: Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1-10
Rounds: Post-IPO Equity
Last Investment Activity: Mar 2, 2024
Founded Date: 2012
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:SCLX
Operating Status: Active
6 Emails
1 Phones
Main email format: ssmith@scilexholding.com (100.0%)
-
Jaisim Shah
CEO & President, Director,CEO & Director, Scilex Holding
j***h@scilexholding.com
-
David J Tarin
Territory Business Manager
d****n@scilexholding.com
-
Jonathan Perkins
Territory Business Manager
j******s@scilexholding.com
-
Chris Ippolito
c*******o@scilexholding.com
-
General Inquiries
info@scilexholding.com
-
General Inquiries
info@scilexpharma.com
HQ: Malvern, Pennsylvania, United States
Par Pharmaceuticals
Par Pharmaceutical develops, manufactures, and marShow more...kets innovative and cost-effective generic pharmaceutical products.
HQ: Malvern, Pennsylvania, United States
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Private
Employees: 1001-5000
Last Investment Activity: Jun 28, 2019
Founded Date: 1978
Number of Exits: 2
Company Type: For Profit
Operating Status: Active
7 Emails
0 Phones
Main email format: sarah.smith@parpharm.com (66.7%)
-
Richard Carlson
c*******d@parpharm.com
-
Jason Rose
j***e@parpharm.com
-
Karam Razooq
k**********q@parpharm.com
-
Marie-Louise Mansour
m******************r@parpharm.com
-
Unclassified inbox
cs.formulations@parpharm.com
-
Unclassified inbox
Thomas.Haughey@parpharm.com
-
Unclassified inbox
john.smith@parpharm.com
HQ: Miami, Florida, United States
OPKO Health
Opko Health engages in the discovery and developmeShow more...nt of novel and proprietary technologies for pharmaceuticals and diagnostics.
HQ: Miami, Florida, United States
Specialized In: Biotechnology, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Debt
Last Investment Activity: Feb 5, 2024
Founded Date: 2005
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NASDAQ:OPK
Operating Status: Active
5 Emails
1 Phones
Main email format: ssmith@opko.com (100.0%)
-
Charles Bishop
CEO, Renal Division
c*****p@opko.com
-
Andria Rae Hernandez
Renal Sales Specialist
a********z@opko.com.If
9***********************7
-
Jeff Kurszewski
National Account Director
j*********i@opko.com
-
Gary Nabel
Chief Innovation Officer
g****l@opko.com
-
General Inquiries
contact@opko.com
HQ: Rochester, New York, United States
AeroSafe Global
AeroSafe Global develops aerogels used in various Show more...transport, biomedical, pharmaceutical, and other temperature-sensitive products.
HQ: Rochester, New York, United States
Specialized In: Pharmaceuticals, Manufacturing & Industrial
Business Type: Private
Employees: 51-100
Rounds: Private Equity
Last Investment Activity: Nov 28, 2023
Founded Date: 1995
Company Type: For Profit
Operating Status: Active
7 Emails
0 Phones
Main email format: ssmith@aerosafeglobal.com (100.0%)
-
David Cortese
Director, Engineering and Automation
d******e@aerosafeglobal.com
-
Kelley Rowan
Human Resources Generalist
k****n@aerosafeglobal.com
-
Alan J Krokenberger
Director Of Engineering
a***********r@aerosafeglobal.com
-
Danner Hickman
Director Corporate Development
d******n@aerosafeglobal.com
-
General Inquiries
info@aerosafeglobal.com
-
Customer Service
support@aerosafeglobal.com
-
General Inquiries
info@americanaerogel.com
HQ: Seoul, Seoul-t'ukpyolsi, South Korea
LG Chem
LG Chem is a chemical company that provides innovaShow more...tive materials and solutions for its customers.
HQ: Seoul, Seoul-t'ukpyolsi, South Korea
Specialized In: Manufacturing & Industrial, Pharmaceuticals
Business Type: Private
Employees: 10001+
Last Investment Activity: Aug 28, 2024
Founded Date: 1947
Number of Exits: 2
Company Type: For Profit
Operating Status: Active
7 Emails
1 Phones
Main email format: sarahs@lgchem.com (100.0%)
-
Anita H
Whoo（后）Tier 1 Cosmetics Agency
a****h@lgchem.com.If
7********7
-
Annie M
Whoo（后）Tier 1 Cosmetics Agency
a****m@lgchem.com
-
Agatha W
Whoo（后）Tier 1 Cosmetics Agency
a*****w@lgchem.com
-
Agnes K
Whoo（后）Tier 1 Cosmetics Agency
a****k@lgchem.com
-
Unclassified inbox
contact.cbl@lgchem.com
-
Unclassified inbox
meejungkim@lgchem.com
-
Unclassified inbox
samueljang@lgchem.com
HQ: Dublin, Dublin, Ireland
Shire
Shire biotechnology company that focuses on servinShow more...g people with rare diseases.
HQ: Dublin, Dublin, Ireland
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics, Wellness
Acquired by: Takeda
Business Type: Public
Employees: 10001+
Rounds: Venture - Series Unknown
Last Investment Activity: May 14, 2024
Founded Date: 1986
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NASDAQ:SHPG
Operating Status: Closed
9 Emails
0 Phones
Main email format: ssmith@shire.com (100.0%)
-
Katelyn Mallozzi
Head of Global Planning and Design
k*******i@shire.com
-
Scott Donald
UK Head of Neuroscience
s*****d@shire.com
-
Nirvan Hulangamuwa
Finance Business Partner
n**********a@shire.com
-
Victor Otcheretko
v*********o@shire.com
-
General Inquiries
info@shirehousing.com
-
General Inquiries
info@shirefoods.com
-
Unclassified inbox
golf@theshirelondon.com
-
Unclassified inbox
shire@woodanilling.wa.gov.au
-
Unclassified inbox
abcdefghij@shire.com
HQ: Boulogne-billancourt, Ile-de-France, France
Ipsen
Ipsen is a global specialty-driven biopharmaceuticShow more...al company focused on innovation and specialty care.
HQ: Boulogne-billancourt, Ile-de-France, France
Specialized In: Biotechnology, Pharmaceuticals
Business Type: Public
Employees: 5001-10000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 25, 2024
Founded Date: 1929
Number of Exits: 5
Company Type: For Profit
Stock Symbol: EPA:IPN
Operating Status: Active
11 Emails
0 Phones
Main email format: sarah.smith@ipsen.com (100.0%)
-
Sandra Silvestri
EVP, Chief Medical Officer, Head of Global Medical Affairs, Patient Safety & Patient Affairs
s**************i@ipsen.com
-
Susan Tinney
s**********y@ipsen.com
-
Karen Hummel
Executive Director, National Health Systems, Medical Affairs
k**********l@ipsen.com
-
Helen Hsu
h*******u@ipsen.com
-
Unclassified inbox
Clinical.trials@ipsen.com
-
Unclassified inbox
corporate.communications@ipsen.com
-
Unclassified inbox
qualitycomplaints.russia.cis@ipsen.com
-
Unclassified inbox
ipsenepe@ipsen.com
-
Unclassified inbox
medical.information.russia.cis@ipsen.com
-
Unclassified inbox
medinfo.uk-ie@ipsen.com
-
Unclassified inbox
contact.web@ipsen.com
HQ: Silver Spring, Maryland, United States
United Therapeutics
United Therapeutics Corporation is a biotechnologyShow more... company focused on the development and commercialization of unique products.
HQ: Silver Spring, Maryland, United States
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 501-1000
Last Investment Activity: Aug 28, 2024
Founded Date: 1996
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:UTHR
Operating Status: Active
3 Emails
0 Phones
Main email format: ssmith@unither.com (100.0%)
-
Heidi Bell
Medical Director, Medical Monitoring
h***l@unither.com
-
Nicole Wilkerson
n********n@unither.com
-
Gil PhD
Senior Vice President and Chief Medical Officer
ggolden@unither.com
-
General Inquiries
info@unither.com
HQ: Seattle, Washington, United States
CTI BioPharma
CTI BioPharma is a biopharmaceutical company develShow more...oping oncology products for the treatment of blood-related cancers.
HQ: Seattle, Washington, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Delisted
Employees: 101-250
Rounds: Post-IPO Debt
Last Investment Activity: Jun 26, 2023
Founded Date: 1991
Company Type: For Profit
Stock Symbol: NASDAQ:CTIC
Operating Status: Active
4 Emails
0 Phones
Main email format: ssmith@ctibiopharma.com (100.0%)
-
Chuck Bianco
c*****o@ctibiopharma.com
-
Natalie Jaynes Brunner
Key Account Manager
n******r@ctibiopharma.com
-
patrizia angiuli
p******i@ctibiopharma.com
-
General Inquiries
medinfo@ctibiopharma.com
HQ: San Diego, California, United States
Rakuten Medical
Rakuten Medical is a biotechnology company that deShow more...velops precision, cell-targeting investigational therapies.
HQ: San Diego, California, United States
Specialized In: Pharmaceuticals, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 101-250
Rounds: Series E
Last Investment Activity: Mar 26, 2024
Founded Date: 2010
Company Type: For Profit
Operating Status: Active
6 Emails
0 Phones
Main email format: ssmith@rakuten-med.com (100.0%)
-
Natalie Huang
People Operations Generalist (HR)
n****g@rakuten-med.com
-
Shashank Basavaraju
Associate Manager, Technical Operations & Global Supply Chain
s*********u@rakuten-med.com
-
Carlos A Garcia
Chief Technical Officer
c*****a@rakuten-med.com
-
Unclassified inbox
info.tw@rakuten-med.com
-
Unclassified inbox
j.d@rakuten-med.com
-
General Inquiries
info@rakuten-med.com
HQ: Mechelen-bovelingen, Limburg, Belgium
Galapagos
Galapagos is a clinical-stage biotechnology companShow more...y, specialized in the discovery and development of small molecule medicines with novel.
HQ: Mechelen-bovelingen, Limburg, Belgium
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Feb 25, 2024
Founded Date: 1999
Company Type: For Profit
Stock Symbol: VIE:GLPG
Operating Status: Active
7 Emails
0 Phones
Main email format: sarah.smith@glpg.com (100.0%)
-
Werner Cautreels
Director
w**************s@glpg.com
-
Francois Normant
Director Human Resources France
f**************t@glpg.com
-
Raphaëlle LACHAT
r**************t@glpg.com
-
General Inquiries
info@glpg.com
-
Customer Service
support@glpg.com
-
Legal Department
legal@glpg.com
-
Unclassified inbox
dpo@glpg.com
HQ: New Delhi, Delhi, India
Mankind Pharma
Mankind Pharma is a pharmaceutical company that deShow more...velops, commercializes, and delivers medicines for urgent medical needs.
HQ: New Delhi, Delhi, India
Specialized In: Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Rounds: Secondary Market
Last Investment Activity: Mar 11, 2024
Founded Date: 1995
Company Type: For Profit
Operating Status: Active
4 Emails
0 Phones
Main email format: sarah.smith@mankindpharma.com (100.0%)
-
Eklavya Juneja
e************a@mankindpharma.com
-
Sarah Bhambre
s***********e@mankindpharma.com
-
Dilip Chaturvedi
d**************i@mankindpharma.com
-
General Inquiries
contact@mankindpharma.com
HQ: Seattle, Washington, United States
Fred Hutchinson
Fred Hutchinson Cancer Research Center provides seShow more...rvices for the prevention, early detection, and treatment of cancer and other diseases.
HQ: Seattle, Washington, United States
Specialized In: Biotechnology, Coaching & Consulting, Healthcare & Medical, Health Diagnostics, Travel & Hospitality, Hospitals & Clinics, Pharmaceuticals
Business Type: Private
Employees: 5001-10000
Rounds: Grant
Last Investment Activity: Aug 9, 2023
Founded Date: 1975
Company Type: For Profit
Operating Status: Active
4 Emails
1 Phones
-
k*****e@fredhutch.org
-
s****m@fredhutch.org
***********
-
a*************n@fredhutch.org
-
Unclassified inbox
communications@fredhutch.org
HQ: Morristown, New Jersey, United States
Alvogen
Alvogen is a manufacturer of pharmaceutical products.
HQ: Morristown, New Jersey, United States
Specialized In: Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Private
Employees: 1001-5000
Rounds: Private Equity
Last Investment Activity: Feb 3, 2023
Founded Date: 2009
Number of Exits: 2
Company Type: For Profit
Operating Status: Active
4 Emails
0 Phones
Main email format: sarah.smith@alvogen.com (100.0%)
-
Kristin Hulda Sverrisdottir
Executive PA to the Chairman and CEO of Alvogen
k*******************r@alvogen.com
-
jasmine shah
VP MA and RA
j**********h@alvogen.com
-
Ripal Gaudana
Principal Scientist ( Product Development)
r***********a@alvogen.com
-
General Inquiries
info@alvogen.com
HQ: New York, New York, United States
Roivant Sciences
Roivant Sciences is a biopharmaceutical company foShow more...cused on the development of medicines and healthcare technologies to patients.
HQ: New York, New York, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 25, 2024
Founded Date: May 2014
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:ROIV
Operating Status: Active
4 Emails
0 Phones
Main email format: sarah.smith@roivant.com (100.0%)
-
Matthew Gline
Chief Financial Officer
m***********e@roivant.com
-
Tanya Shaby
Partner, Legal
t*********y@roivant.com
-
Jamie Schiff
Software Engineer
j**********f@roivant.com
-
General Inquiries
info@roivant.com
HQ: Paris, Ile-de-France, France
Sanofi
Sanofi is a healthcare company that provides treatShow more...ments and the protection of life-saving vaccines.
HQ: Paris, Ile-de-France, France
Specialized In: Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 21, 2024
Founded Date: 1973
Number of Exits: 12
Company Type: For Profit
Stock Symbol: NYSE:SNY
Operating Status: Active
5 Emails
0 Phones
Main email format: sarah.smith@sanofi.com (66.7%)
-
Patricia Roselle
Global Head, Patient Network Management
p*************e@sanofi.com
-
Guy Griebel
Senior Director Sanofi Genzyme Neuroscience
g*********l@sanofi.com
-
Anne Dulac-Gaume
Corporate Business Development - Director
a*************e@sanofi.com
-
Unclassified inbox
caio.inbox@sanofi.com
-
Customer Service
customersupport@sanofi.com
HQ: Pasadena, California, United States
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology compaShow more...ny that focuses on the development of medicine to treat diseases with a genetic origin.
HQ: Pasadena, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Technology & Software, Pharmaceuticals
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Feb 7, 2024
Founded Date: 1989
Company Type: For Profit
Stock Symbol: NASDAQ:ARWR
Operating Status: Active
6 Emails
0 Phones
Main email format: ssmith@arrowheadpharma.com (100.0%)
-
Bruce Given
Chief Operating Officer
b****n@arrowheadpharma.com
-
Holly Hamilton
Associate Director, Bioassays
h*******n@arrowheadpharma.com
-
Matthew Cyr
Postbaccalaureate Fellow
m**r@arrowheadpharma.com
-
General Inquiries
info@arrowheadpharma.com
-
Legal Department
legal@arrowheadpharma.com
-
General Inquiries
info@arrowres.com
HQ: Paris, Ile-de-France, France
Unither Pharmaceuticals
Unither Pharmaceuticals is a French manufacturer oShow more...f dosage forms for pharmaceutical laboratories and generic products.
HQ: Paris, Ile-de-France, France
Specialized In: Biotechnology, Manufacturing & Industrial, Pharmaceuticals
Acquired by: Ardian
Business Type: Private
Employees: 1001-5000
Rounds: Private Equity
Last Investment Activity: Jul 2, 2024
Founded Date: 1993
Company Type: For Profit
Operating Status: Active
6 Emails
0 Phones
Main email format: sarah.smith@unither-pharma.com (100.0%)
-
Perrine Millereux
Human Resources Manager
p***************x@unither-pharma.com
-
Olivier Bellot
o************t@unither-pharma.com
-
Kevin Colangelo
General Manager North America Unither Pharmacuiticals
k*************o@unither-pharma.com
-
Admin Team
admin@unither-pharma.com
-
General Inquiries
contact@unither-pharma.com
-
Unclassified inbox
unither@unither-pharma.com
HQ: London, England, United Kingdom
BTG International
BTG is a global healthcare company focused on InteShow more...rventional Medicine.
HQ: London, England, United Kingdom
Specialized In: Pharmaceuticals, Hospitals & Clinics, Healthcare & Medical, Manufacturing & Industrial
Business Type: Private
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Jan 27, 2020
Founded Date: 1948
Number of Exits: 2
Company Type: For Profit
Operating Status: Closed
4 Emails
0 Phones
Main email format: sarah.smith@btgplc.com (50.0%)
-
Darby Citizen Kane
National Sales Manager Acute Care
d********e@btgplc.com
-
Richard Skellie
r*******e@btgplc.com
-
Joe Neale
Chief Technology Officer & Head of Respiratory Innovation Center
j*******e@btgplc.com
-
Customer Service
customerservice@btgplc.com
We’re in beta testing! Sign up for free to unlock all the information on this page — no credit card required.